Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
quinacrine | [no description available] | medium | 8 | 0 | acridines; aromatic ether; organochlorine compound; tertiary amino compound | antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor |
gallopamil | [no description available] | medium | 1 | 0 | benzenes; organic amino compound | |
4-aminopyridine | [no description available] | medium | 1 | 0 | aminopyridine; aromatic amine | avicide; orphan drug; potassium channel blocker |
phenytoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | anticonvulsant; drug allergen; sodium channel blocker; teratogenic agent |
8-(4-sulfophenyl)theophylline | [no description available] | medium | 1 | 0 | | |
8-phenyltheophylline | [no description available] | medium | 1 | 0 | | |
theophylline | [no description available] | medium | 1 | 0 | dimethylxanthine | adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent |
amitriptyline | [no description available] | medium | 40 | 0 | carbotricyclic compound; tertiary amine | adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic |
anisindione | [no description available] | medium | 1 | 0 | aromatic ketone; beta-diketone | anticoagulant; vitamin K antagonist |
baclofen | [no description available] | medium | 1 | 0 | amino acid zwitterion; gamma-amino acid; monocarboxylic acid; monochlorobenzenes; primary amino compound | central nervous system depressant; GABA agonist; muscle relaxant |
benzocaine | [no description available] | medium | 1 | 0 | benzoate ester; substituted aniline | allergen; antipruritic drug; sensitiser; topical anaesthetic |
bepridil | [no description available] | medium | 2 | 0 | pyrrolidines; tertiary amine | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
biperiden | [no description available] | medium | 1 | 0 | piperidines; tertiary alcohol; tertiary amino compound | antidote to sarin poisoning; antidyskinesia agent; antiparkinson drug; muscarinic antagonist; parasympatholytic |
bupivacaine | [no description available] | medium | 1 | 0 | aromatic amide; piperidinecarboxamide; tertiary amino compound | |
buspirone | [no description available] | medium | 3 | 0 | azaspiro compound; N-alkylpiperazine; N-arylpiperazine; organic heteropolycyclic compound; piperidones; pyrimidines | anxiolytic drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; sedative; serotonergic agonist |
butacaine | [no description available] | medium | 1 | 0 | benzoate ester | |
butamben | [no description available] | medium | 1 | 0 | amino acid ester; benzoate ester; primary amino compound; substituted aniline | local anaesthetic |
caffeine | [no description available] | medium | 5 | 0 | purine alkaloid; trimethylxanthine | adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic |
verapamil | [no description available] | medium | 1 | 0 | aromatic ether; nitrile; polyether; tertiary amino compound | |
carbamazepine | [no description available] | medium | 4 | 0 | dibenzoazepine; ureas | analgesic; anticonvulsant; antimanic drug; drug allergen; EC 3.5.1.98 (histone deacetylase) inhibitor; environmental contaminant; glutamate transporter activator; mitogen; non-narcotic analgesic; sodium channel blocker; xenobiotic |
chlordiazepoxide | [no description available] | medium | 2 | 0 | benzodiazepine | |
chlorpheniramine | [no description available] | medium | 2 | 0 | monochlorobenzenes; pyridines; tertiary amino compound | anti-allergic agent; antidepressant; antipruritic drug; H1-receptor antagonist; histamine antagonist; serotonin uptake inhibitor |
chlorpromazine | [no description available] | medium | 18 | 0 | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
cimetidine | [no description available] | medium | 3 | 0 | aliphatic sulfide; guanidines; imidazoles; nitrile | adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
clomipramine | [no description available] | medium | 22 | 0 | dibenzoazepine | anticoronaviral agent; antidepressant; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; serotonergic antagonist; serotonergic drug; serotonin uptake inhibitor |
cyproheptadine | [no description available] | medium | 1 | 0 | piperidines; tertiary amine | anti-allergic agent; antipruritic drug; gastrointestinal drug; H1-receptor antagonist; serotonergic antagonist |
desipramine | [no description available] | medium | 42 | 0 | dibenzoazepine; secondary amino compound | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; cholinergic antagonist; drug allergen; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; serotonin uptake inhibitor |
desipramine | [no description available] | medium | 42 | 1 | dibenzoazepine; secondary amino compound | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; cholinergic antagonist; drug allergen; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; serotonin uptake inhibitor |
diazepam | [no description available] | medium | 5 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic |
diazoxide | [no description available] | medium | 1 | 0 | benzothiadiazine; organochlorine compound; sulfone | antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent |
dibucaine | [no description available] | medium | 1 | 0 | aromatic ether; monocarboxylic acid amide; tertiary amino compound | topical anaesthetic |
dicyclomine | [no description available] | medium | 1 | 0 | carboxylic ester; tertiary amine | antispasmodic drug; muscarinic antagonist; parasympatholytic |
diphenidol | [no description available] | medium | 2 | 0 | benzenes; piperidines; tertiary alcohol | antiemetic |
dilazep | [no description available] | medium | 1 | 0 | benzoate ester; diazepane; diester; methoxybenzenes | cardioprotective agent; platelet aggregation inhibitor; vasodilator agent |
diphenhydramine | [no description available] | medium | 1 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
dipyridamole | [no description available] | medium | 1 | 0 | piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol | adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent |
doxepin | [no description available] | medium | 7 | 0 | dibenzooxepine; tertiary amino compound | antidepressant |
droperidol | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; organofluorine compound | anaesthesia adjuvant; antiemetic; dopaminergic antagonist; first generation antipsychotic |
etazolate | [no description available] | medium | 1 | 0 | ethyl ester; hydrazone; pyrazolopyridine | alpha-secretase activator; antidepressant; antipsychotic agent; anxiolytic drug; GABA agent; neuroprotective agent; phosphodiesterase IV inhibitor |
felodipine | [no description available] | medium | 1 | 0 | dichlorobenzene; dihydropyridine; ethyl ester; methyl ester | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
flufenamic acid | [no description available] | medium | 2 | 0 | aromatic amino acid; organofluorine compound | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
fluphenazine | [no description available] | medium | 1 | 0 | N-alkylpiperazine; organofluorine compound; phenothiazines | anticoronaviral agent; dopaminergic antagonist; phenothiazine antipsychotic drug |
flumazenil | [no description available] | medium | 1 | 0 | ethyl ester; imidazobenzodiazepine; organofluorine compound | antidote to benzodiazepine poisoning; GABA antagonist |
haloperidol | [no description available] | medium | 7 | 0 | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
hydroxyzine | [no description available] | medium | 5 | 0 | hydroxyether; monochlorobenzenes; N-alkylpiperazine | anticoronaviral agent; antipruritic drug; anxiolytic drug; dermatologic drug; H1-receptor antagonist |
lidocaine | [no description available] | medium | 3 | 0 | benzenes; monocarboxylic acid amide; tertiary amino compound | anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic |
ici 118551 | [no description available] | medium | 1 | 0 | indanes | |
imipramine | [no description available] | medium | 52 | 0 | dibenzoazepine | adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
imipramine | [no description available] | medium | 52 | 4 | dibenzoazepine | adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
indomethacin | [no description available] | medium | 1 | 0 | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic |
1-methyl-3-isobutylxanthine | [no description available] | medium | 1 | 0 | 3-isobutyl-1-methylxanthine | |
loperamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; monochlorobenzenes; piperidines; tertiary alcohol | anticoronaviral agent; antidiarrhoeal drug; mu-opioid receptor agonist |
mepivacaine | [no description available] | medium | 1 | 0 | piperidinecarboxamide | drug allergen; local anaesthetic |
benzoic acid [2-methyl-2-(propylamino)propyl] ester | [no description available] | medium | 1 | 0 | benzoate ester | |
metoprolol | [no description available] | medium | 2 | 0 | aromatic ether; propanolamine; secondary alcohol; secondary amino compound | antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic |
mianserin | [no description available] | medium | 29 | 0 | dibenzoazepine | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; H1-receptor antagonist; histamine agonist; sedative; serotonergic antagonist |
nifedipine | [no description available] | medium | 1 | 0 | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
nisoldipine | [no description available] | medium | 1 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester | |
nitrendipine | [no description available] | medium | 2 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester | antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent |
nortriptyline | [no description available] | medium | 10 | 0 | organic tricyclic compound; secondary amine | adrenergic uptake inhibitor; analgesic; antidepressant; antineoplastic agent; apoptosis inducer; drug metabolite |
oxethazaine | [no description available] | medium | 1 | 0 | amino acid amide | |
benoxinate | [no description available] | medium | 1 | 0 | amino acid ester; benzoate ester; substituted aniline; tertiary amino compound | drug allergen; local anaesthetic; topical anaesthetic |
papaverine | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines | antispasmodic drug; vasodilator agent |
pentobarbital | [no description available] | medium | 2 | 0 | barbiturates | GABAA receptor agonist |
pheniramine | [no description available] | medium | 2 | 0 | pyridines; tertiary amino compound | |
phenobarbital | [no description available] | medium | 5 | 0 | barbiturates | anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative |
phenoxybenzamine | [no description available] | medium | 3 | 0 | aromatic amine | |
practolol | [no description available] | medium | 1 | 0 | acetamides; ethanolamines; propanolamine; secondary alcohol; secondary amino compound | anti-arrhythmia drug; beta-adrenergic antagonist |
pramoxine | [no description available] | medium | 1 | 0 | aromatic ether; morpholines | local anaesthetic |
prazosin | [no description available] | medium | 4 | 0 | aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
prilocaine | [no description available] | medium | 1 | 0 | amino acid amide; monocarboxylic acid amide | anticonvulsant; local anaesthetic |
proadifen | [no description available] | medium | 1 | 0 | diarylmethane | |
procainamide | [no description available] | medium | 3 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
procaine | [no description available] | medium | 4 | 0 | benzoate ester; substituted aniline; tertiary amino compound | central nervous system depressant; drug allergen; local anaesthetic; peripheral nervous system drug |
promazine | [no description available] | medium | 6 | 0 | phenothiazines; tertiary amine | antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; serotonergic antagonist |
promethazine | [no description available] | medium | 3 | 0 | phenothiazines; tertiary amine | anti-allergic agent; anticoronaviral agent; antiemetic; antipruritic drug; H1-receptor antagonist; local anaesthetic; sedative |
proxymetacaine | [no description available] | medium | 1 | 0 | benzoate ester | |
protriptyline | [no description available] | medium | 4 | 0 | carbotricyclic compound | antidepressant |
pyrilamine | [no description available] | medium | 2 | 0 | aromatic ether; ethylenediamine derivative | H1-receptor antagonist |
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone | [no description available] | medium | 1 | 0 | methoxybenzenes | |
rolipram | [no description available] | medium | 1 | 0 | pyrrolidin-2-ones | antidepressant; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor |
secobarbital | [no description available] | medium | 2 | 0 | barbiturates | anaesthesia adjuvant; GABA modulator; sedative |
sotalol | [no description available] | medium | 3 | 0 | ethanolamines; secondary alcohol; secondary amino compound; sulfonamide | anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic |
spiperone | [no description available] | medium | 2 | 0 | aromatic ketone; azaspiro compound; organofluorine compound; piperidines; tertiary amino compound | alpha-adrenergic antagonist; antipsychotic agent; dopaminergic antagonist; psychotropic drug; serotonergic antagonist |
tetracaine | [no description available] | medium | 1 | 0 | benzoate ester; tertiary amino compound | local anaesthetic |
thioridazine | [no description available] | medium | 6 | 0 | phenothiazines; piperidines | alpha-adrenergic antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist |
trazodone | [no description available] | medium | 5 | 0 | monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazolopyridine | adrenergic antagonist; antidepressant; anxiolytic drug; H1-receptor antagonist; sedative; serotonin uptake inhibitor |
trequinsin | [no description available] | medium | 1 | 0 | pyridopyrimidine | |
trifluoperazine | [no description available] | medium | 5 | 0 | N-alkylpiperazine; N-methylpiperazine; organofluorine compound; phenothiazines | antiemetic; calmodulin antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor; phenothiazine antipsychotic drug |
reserpine | [no description available] | medium | 6 | 0 | alkaloid ester; methyl ester; yohimban alkaloid | adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic |
phentolamine | [no description available] | medium | 4 | 0 | imidazoles; phenols; substituted aniline; tertiary amino compound | alpha-adrenergic antagonist; vasodilator agent |
hexobendine | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
dichloroisoproterenol | [no description available] | medium | 1 | 0 | | |
tetraethylammonium chloride | [no description available] | medium | 1 | 0 | organic chloride salt; quaternary ammonium salt | potassium channel blocker |
tetrabenazine | [no description available] | medium | 1 | 0 | benzoquinolizine; cyclic ketone; tertiary amino compound | |
piperoxan | [no description available] | medium | 1 | 0 | | |
nifenalol | [no description available] | medium | 1 | 0 | C-nitro compound | |
brompheniramine | [no description available] | medium | 4 | 0 | organobromine compound; pyridines | anti-allergic agent; H1-receptor antagonist |
propoxycaine | [no description available] | medium | 1 | 0 | benzoate ester | |
dimethisoquin | [no description available] | medium | 1 | 0 | isoquinolines | |
parethoxycaine | [no description available] | medium | 1 | 0 | benzoate ester | |
yohimbine | [no description available] | medium | 6 | 0 | methyl 17-hydroxy-20xi-yohimban-16-carboxylate | alpha-adrenergic antagonist; dopamine receptor D2 antagonist; serotonergic antagonist |
2-chloroadenosine | [no description available] | medium | 1 | 0 | purine nucleoside | |
prenylamine | [no description available] | medium | 3 | 0 | diarylmethane | |
bicuculline | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines | agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin |
hexylcaine | [no description available] | medium | 1 | 0 | benzoate ester | |
piperocaine | [no description available] | medium | 1 | 0 | benzoate ester | |
diperodon | [no description available] | medium | 1 | 0 | carbamate ester | |
cyclomethycaine | [no description available] | medium | 1 | 0 | benzoate ester | |
carcainium chloride | [no description available] | medium | 1 | 0 | | |
azacyclonol | [no description available] | medium | 1 | 0 | diarylmethane | |
butoxamine | [no description available] | medium | 1 | 0 | | |
dexpropranolol | [no description available] | medium | 1 | 0 | propranolol | |
carticaine | [no description available] | medium | 1 | 0 | thiophenecarboxylic acid | |
timolol | [no description available] | medium | 1 | 0 | timolol | anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist |
butaclamol | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound | |
etidocaine | [no description available] | medium | 2 | 0 | amino acid amide | local anaesthetic |
diltiazem | [no description available] | medium | 1 | 0 | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent; calcium channel blocker; vasodilator agent |
Arbaclofen | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
colforsin | [no description available] | medium | 2 | 0 | acetate ester; cyclic ketone; labdane diterpenoid; organic heterotricyclic compound; tertiary alpha-hydroxy ketone; triol | adenylate cyclase agonist; anti-HIV agent; antihypertensive agent; plant metabolite; platelet aggregation inhibitor; protein kinase A agonist |
opromazine | [no description available] | medium | 1 | 0 | phenothiazines | |
corynanthine | [no description available] | medium | 1 | 0 | yohimban alkaloid | |
phenylisopropyladenosine | [no description available] | medium | 1 | 0 | aromatic amine; benzenes; hydrocarbyladenosine; purine nucleoside; secondary amino compound | adenosine A1 receptor agonist; neuroprotective agent |
w 7 | [no description available] | medium | 1 | 0 | | |
2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene | [no description available] | medium | 1 | 0 | | |
rac 109 | [no description available] | medium | 1 | 0 | | |
atropine | [no description available] | medium | 4 | 0 | | |
strychnine | [no description available] | medium | 2 | 0 | monoterpenoid indole alkaloid; organic heteroheptacyclic compound | avicide; cholinergic antagonist; glycine receptor antagonist; neurotransmitter agent; rodenticide |
quinidine | [no description available] | medium | 4 | 0 | cinchona alkaloid | alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker |
cocaine | [no description available] | medium | 6 | 0 | benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid | adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
diethylstilbestrol | [no description available] | medium | 1 | 0 | olefinic compound; polyphenol | antifungal agent; antineoplastic agent; autophagy inducer; calcium channel blocker; carcinogenic agent; EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; endocrine disruptor; xenoestrogen |
rauwolscine | [no description available] | medium | 1 | 0 | methyl 17-hydroxy-20xi-yohimban-16-carboxylate | |
chlorprothixene | [no description available] | medium | 1 | 0 | chlorprothixene | |
flunarizine | [no description available] | medium | 1 | 0 | diarylmethane | |
thiothixene | [no description available] | medium | 2 | 0 | N-methylpiperazine | anticoronaviral agent |
cinnarizine | [no description available] | medium | 1 | 0 | diarylmethane; N-alkylpiperazine; olefinic compound | anti-allergic agent; antiemetic; calcium channel blocker; geroprotector; H1-receptor antagonist; histamine antagonist; muscarinic antagonist |
quinine | [no description available] | medium | 1 | 0 | cinchona alkaloid | antimalarial; muscle relaxant; non-narcotic analgesic |
codeine | [no description available] | medium | 1 | 0 | morphinane alkaloid; organic heteropentacyclic compound | antitussive; drug allergen; environmental contaminant; opioid analgesic; opioid receptor agonist; prodrug; xenobiotic |
morphine | [no description available] | medium | 3 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound | anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic |
levorphanol | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
dextrorphan | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
zimeldine | [no description available] | medium | 9 | 0 | styrenes | |
1-methyl-d-lysergic acid butanolamide | [no description available] | medium | 1 | 0 | ergot alkaloid; monocarboxylic acid amide | serotonergic antagonist; sympatholytic agent; vasoconstrictor agent |
scopolamine hydrobromide | [no description available] | medium | 1 | 0 | | |
bupropion | [no description available] | medium | 3 | 0 | aromatic ketone; monochlorobenzenes; secondary amino compound | antidepressant; environmental contaminant; xenobiotic |
3-methylcholanthrene | [no description available] | medium | 2 | 0 | ortho- and peri-fused polycyclic arene | aryl hydrocarbon receptor agonist; carcinogenic agent |
tacrine | [no description available] | medium | 2 | 0 | acridines; aromatic amine | EC 3.1.1.7 (acetylcholinesterase) inhibitor |
acetaminophen | [no description available] | medium | 3 | 0 | acetamides; phenols | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
amiodarone | [no description available] | medium | 4 | 0 | 1-benzofurans; aromatic ketone; organoiodine compound; tertiary amino compound | cardiovascular drug |
aspirin | [no description available] | medium | 2 | 0 | benzoic acids; phenyl acetates; salicylates | anticoagulant; antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; EC 1.1.1.188 (prostaglandin-F synthase) inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; plant activator; platelet aggregation inhibitor; prostaglandin antagonist; teratogenic agent |
bicalutamide | [no description available] | medium | 2 | 0 | (trifluoromethyl)benzenes; monocarboxylic acid amide; monofluorobenzenes; nitrile; sulfone; tertiary alcohol | |
chlorcyclizine | [no description available] | medium | 4 | 0 | diarylmethane | |
chloroquine | [no description available] | medium | 12 | 0 | aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug |
ciprofibrate | [no description available] | medium | 3 | 0 | cyclopropanes; monocarboxylic acid; organochlorine compound | antilipemic drug |
citalopram | [no description available] | medium | 4 | 0 | 2-benzofurans; cyclic ether; nitrile; organofluorine compound; tertiary amino compound | |
clofibrate | [no description available] | medium | 2 | 0 | aromatic ether; ethyl ester; monochlorobenzenes | anticholesteremic drug; antilipemic drug; geroprotector; PPARalpha agonist |
deferoxamine | [no description available] | medium | 2 | 0 | acyclic desferrioxamine | bacterial metabolite; ferroptosis inhibitor; iron chelator; siderophore |
diclofenac | [no description available] | medium | 2 | 0 | amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
diflunisal | [no description available] | medium | 2 | 0 | monohydroxybenzoic acid; organofluorine compound | non-narcotic analgesic; non-steroidal anti-inflammatory drug |
donepezil | [no description available] | medium | 2 | 0 | aromatic ether; indanones; piperidines; racemate | EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; nootropic agent |
doxapram | [no description available] | medium | 2 | 0 | morpholines; pyrrolidin-2-ones | central nervous system stimulant |
ethyl loflazepate | [no description available] | medium | 3 | 0 | organic molecular entity | |
felbamate | [no description available] | medium | 2 | 0 | carbamate ester | anticonvulsant; neuroprotective agent |
fenfluramine | [no description available] | medium | 6 | 0 | (trifluoromethyl)benzenes; secondary amino compound | appetite depressant; serotonergic agonist; serotonin uptake inhibitor |
fenofibrate | [no description available] | medium | 2 | 0 | aromatic ether; chlorobenzophenone; isopropyl ester; monochlorobenzenes | antilipemic drug; environmental contaminant; geroprotector; xenobiotic |
fluoxetine | [no description available] | medium | 12 | 0 | (trifluoromethyl)benzenes; aromatic ether; secondary amino compound | |
flutamide | [no description available] | medium | 2 | 0 | (trifluoromethyl)benzenes; monocarboxylic acid amide | androgen antagonist; antineoplastic agent |
gemfibrozil | [no description available] | medium | 3 | 0 | aromatic ether | antilipemic drug |
homochlorocyclizine | [no description available] | medium | 3 | 0 | diarylmethane | |
hydroxyurea | [no description available] | medium | 2 | 0 | one-carbon compound; ureas | antimetabolite; antimitotic; antineoplastic agent; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; genotoxin; immunomodulator; radical scavenger; teratogenic agent |
ketoconazole | [no description available] | medium | 3 | 0 | dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine | |
maprotiline | [no description available] | medium | 8 | 0 | anthracenes | |
meclizine | [no description available] | medium | 3 | 0 | diarylmethane | |
metformin | [no description available] | medium | 3 | 0 | guanidines | environmental contaminant; geroprotector; hypoglycemic agent; xenobiotic |
methadone | [no description available] | medium | 2 | 0 | benzenes; diarylmethane; ketone; tertiary amino compound | |
methapyrilene | [no description available] | medium | 3 | 0 | ethylenediamine derivative | anti-allergic agent; carcinogenic agent; H1-receptor antagonist; sedative |
oxidopamine | [no description available] | medium | 3 | 0 | benzenetriol; catecholamine; primary amino compound | drug metabolite; human metabolite; neurotoxin |
perhexiline | [no description available] | medium | 4 | 0 | piperidines | cardiovascular drug |
phenacetin | [no description available] | medium | 3 | 0 | acetamides; aromatic ether | cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug |
suramin | [no description available] | medium | 3 | 0 | naphthalenesulfonic acid; phenylureas; secondary carboxamide | angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug |
temozolomide | [no description available] | medium | 2 | 0 | imidazotetrazine; monocarboxylic acid amide; triazene derivative | alkylating agent; antineoplastic agent; prodrug |
tilorone | [no description available] | medium | 4 | 0 | aromatic ether; diether; fluoren-9-ones; tertiary amino compound | anti-inflammatory agent; antineoplastic agent; antiviral agent; interferon inducer; nicotinic acetylcholine receptor agonist |
pirinixic acid | [no description available] | medium | 2 | 0 | aryl sulfide; organochlorine compound; pyrimidines | |
carbon tetrachloride | [no description available] | medium | 2 | 0 | chlorocarbon; chloromethanes | hepatotoxic agent; refrigerant |
physostigmine | [no description available] | medium | 3 | 0 | carbamate ester; indole alkaloid | antidote to curare poisoning; EC 3.1.1.8 (cholinesterase) inhibitor; miotic |
ethinyl estradiol | [no description available] | medium | 3 | 0 | 17-hydroxy steroid; 3-hydroxy steroid; terminal acetylenic compound | xenoestrogen |
colchicine | [no description available] | medium | 2 | 0 | alkaloid; colchicine | anti-inflammatory agent; gout suppressant; mutagen |
chloroform | [no description available] | medium | 2 | 0 | chloromethanes; one-carbon compound | carcinogenic agent; central nervous system drug; inhalation anaesthetic; non-polar solvent; refrigerant |
triparanol | [no description available] | medium | 6 | 0 | stilbenoid | anticoronaviral agent |
cyclizine | [no description available] | medium | 4 | 0 | N-alkylpiperazine | antiemetic; central nervous system depressant; cholinergic antagonist; H1-receptor antagonist; local anaesthetic |
hydrazine | [no description available] | medium | 3 | 0 | azane; hydrazines | EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor |
norchlorcyclizine | [no description available] | medium | 3 | 0 | | |
N-[(2-chlorophenyl)methyl]-1-[4-[[(2-chlorophenyl)methylamino]methyl]cyclohexyl]methanamine | [no description available] | medium | 3 | 0 | aromatic amine | |
cyproterone acetate | [no description available] | medium | 2 | 0 | 20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; chlorinated steroid; steroid ester | androgen antagonist; geroprotector; progestin |
chlorphentermine | [no description available] | medium | 20 | 0 | amphetamines | |
emetine | [no description available] | medium | 3 | 0 | isoquinoline alkaloid; pyridoisoquinoline | antiamoebic agent; anticoronaviral agent; antiinfective agent; antimalarial; antineoplastic agent; antiprotozoal drug; antiviral agent; autophagy inhibitor; emetic; expectorant; plant metabolite; protein synthesis inhibitor |
1-naphthylisothiocyanate | [no description available] | medium | 2 | 0 | isothiocyanate | insecticide |
erythromycin | [no description available] | medium | 4 | 0 | cyclic ketone; erythromycin | |
paraquat | [no description available] | medium | 3 | 0 | organic cation | geroprotector; herbicide |
stavudine | [no description available] | medium | 2 | 0 | dihydrofuran; nucleoside analogue; organic molecular entity | antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
clomacran | [no description available] | medium | 3 | 0 | acridines | |
ethionine | [no description available] | medium | 2 | 0 | S-ethylhomocysteine | antimetabolite; carcinogenic agent |
indoramin | [no description available] | medium | 3 | 0 | tryptamines | |
amineptin | [no description available] | medium | 2 | 0 | amino acid; carbocyclic fatty acid; carbotricyclic compound; secondary amino compound | antidepressant; dopamine uptake inhibitor |
zidovudine | [no description available] | medium | 3 | 0 | azide; pyrimidine 2',3'-dideoxyribonucleoside | antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor |
tobramycin | [no description available] | medium | 3 | 0 | amino cyclitol glycoside | antibacterial agent; antimicrobial agent; toxin |
etoposide | [no description available] | medium | 3 | 0 | beta-D-glucoside; furonaphthodioxole; organic heterotetracyclic compound | antineoplastic agent; DNA synthesis inhibitor |
amikacin | [no description available] | medium | 4 | 0 | alpha-D-glucoside; amino cyclitol glycoside; aminoglycoside; carboxamide | antibacterial drug; antimicrobial agent; nephrotoxin |
methyldopa | [no description available] | medium | 4 | 0 | L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent |
nonachlazine | [no description available] | medium | 2 | 0 | | |
zileuton | [no description available] | medium | 2 | 0 | 1-benzothiophenes; ureas | anti-asthmatic drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; ferroptosis inhibitor; leukotriene antagonist; non-steroidal anti-inflammatory drug |
hexestrol bis(diethylaminoethyl ether) | [no description available] | medium | 3 | 0 | stilbenoid | |
synthalin a | [no description available] | medium | 2 | 0 | guanidines | hepatotoxic agent; hypoglycemic agent; nephrotoxin |
disobutamide | [no description available] | medium | 3 | 0 | acetamides | |
2-(4'-methylpiperazino-1-methyl)-1,3-diazafluoranthene 1-oxide | [no description available] | medium | 3 | 0 | | |
methotrexate | [no description available] | medium | 2 | 0 | dicarboxylic acid; monocarboxylic acid amide; pteridines | abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent |
glucosamine | [no description available] | medium | 2 | 0 | D-glucosamine | Escherichia coli metabolite; geroprotector; mouse metabolite |
abacavir | [no description available] | medium | 2 | 0 | 2,6-diaminopurines | antiviral drug; drug allergen; HIV-1 reverse transcriptase inhibitor |
netilmicin | [no description available] | medium | 3 | 0 | | |
clindamycin | [no description available] | medium | 3 | 0 | | |
azaserine | [no description available] | medium | 2 | 0 | carboxylic ester; diazo compound; L-serine derivative; non-proteinogenic L-alpha-amino acid | antifungal agent; antimetabolite; antimicrobial agent; antineoplastic agent; glutamine antagonist; immunosuppressive agent; metabolite |
dibekacin | [no description available] | medium | 3 | 0 | kanamycins | antibacterial agent; protein synthesis inhibitor |
sulindac | [no description available] | medium | 2 | 0 | monocarboxylic acid; organofluorine compound; sulfoxide | analgesic; antineoplastic agent; antipyretic; apoptosis inducer; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug; tocolytic agent |
thioacetamide | [no description available] | medium | 2 | 0 | thiocarboxamide | hepatotoxic agent |
tamoxifen | [no description available] | medium | 5 | 0 | stilbenoid; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator |
stilbamidine | [no description available] | medium | 3 | 0 | | |
ceftazidime | [no description available] | medium | 3 | 0 | cephalosporin; oxime O-ether | antibacterial drug; drug allergen; EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor |
famotidine | [no description available] | medium | 2 | 0 | 1,3-thiazoles; guanidines; sulfonamide | anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
dantrolene | [no description available] | medium | 2 | 0 | | |
gentamicin sulfate | [no description available] | medium | 2 | 0 | | |
azacosterol | [no description available] | medium | 3 | 0 | | |
hypoglycin a | [no description available] | medium | 2 | 0 | L-alpha-amino acid | |
amodiaquine hydrochloride | [no description available] | medium | 3 | 0 | | |
valproate sodium | [no description available] | medium | 1 | 0 | organic sodium salt | geroprotector |
chlortetracycline | [no description available] | medium | 3 | 0 | | |
piroxicam | [no description available] | medium | 2 | 0 | benzothiazine; monocarboxylic acid amide; pyridines | analgesic; antirheumatic drug; cyclooxygenase 1 inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug |
demeclocycline | [no description available] | medium | 2 | 0 | | |
rolitetracycline | [no description available] | medium | 2 | 0 | | |
rifampin | [no description available] | medium | 2 | 0 | cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion | angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor |
clozapine | [no description available] | medium | 5 | 0 | benzodiazepine; N-arylpiperazine; N-methylpiperazine; organochlorine compound | adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; GABA antagonist; histamine antagonist; muscarinic antagonist; second generation antipsychotic; serotonergic antagonist; xenobiotic |
adenine | [no description available] | medium | 1 | 0 | 6-aminopurines; purine nucleobase | Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
benzyl alcohol | [no description available] | medium | 1 | 0 | benzyl alcohols | antioxidant; fragrance; metabolite; solvent |
betaine | [no description available] | medium | 1 | 0 | amino-acid betaine; glycine derivative | fundamental metabolite |
lactic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid | algal metabolite; Daphnia magna metabolite |
glycine | [no description available] | medium | 1 | 0 | alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical |
glycerol | [no description available] | medium | 1 | 0 | alditol; triol | algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent |
alpha-glycerophosphoric acid | [no description available] | medium | 1 | 0 | glycerol monophosphate | algal metabolite; human metabolite |
histamine | [no description available] | medium | 3 | 0 | aralkylamino compound; imidazoles | human metabolite; mouse metabolite; neurotransmitter |
inositol | [no description available] | medium | 1 | 0 | cyclitol; hexol | |
niacin | [no description available] | medium | 1 | 0 | pyridine alkaloid; pyridinemonocarboxylic acid; vitamin B3 | antidote; antilipemic drug; EC 3.5.1.19 (nicotinamidase) inhibitor; Escherichia coli metabolite; human urinary metabolite; metabolite; mouse metabolite; plant metabolite; vasodilator agent |
succinic acid | [no description available] | medium | 1 | 0 | alpha,omega-dicarboxylic acid; C4-dicarboxylic acid | anti-ulcer drug; fundamental metabolite; micronutrient; nutraceutical; radiation protective agent |
methacholine | [no description available] | medium | 1 | 0 | acetate ester; quaternary ammonium ion | bronchoconstrictor agent; cholinergic agonist; epitope; muscarinic agonist; vasodilator agent |
albendazole | [no description available] | medium | 1 | 0 | aryl sulfide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | anthelminthic drug; microtubule-destabilising agent; tubulin modulator |
amantadine | [no description available] | medium | 2 | 0 | adamantanes; primary aliphatic amine | analgesic; antiparkinson drug; antiviral drug; dopaminergic agent; NMDA receptor antagonist; non-narcotic analgesic |
ambroxol | [no description available] | medium | 2 | 0 | aromatic amine | |
aminoglutethimide | [no description available] | medium | 1 | 0 | dicarboximide; piperidones; substituted aniline | adrenergic agent; anticonvulsant; antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor |
antazoline | [no description available] | medium | 1 | 0 | aromatic amine; imidazolines; tertiary amino compound | cholinergic antagonist; H1-receptor antagonist; xenobiotic |
barbital | [no description available] | medium | 1 | 0 | barbiturates | drug allergen |
bendroflumethiazide | [no description available] | medium | 1 | 0 | benzothiadiazine; sulfonamide | antihypertensive agent; diuretic |
benzamide | [no description available] | medium | 2 | 0 | benzamides | |
benzquinamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide | antiemetic; antipsychotic agent; H1-receptor antagonist; muscarinic antagonist; sedative |
bethanidine | [no description available] | medium | 1 | 0 | guanidines | adrenergic antagonist; antihypertensive agent |
betaxolol | [no description available] | medium | 1 | 0 | propanolamine | antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
bisacodyl | [no description available] | medium | 1 | 0 | diarylmethane | |
bromhexine | [no description available] | medium | 2 | 0 | organobromine compound; substituted aniline; tertiary amino compound | mucolytic |
bunitrolol | [no description available] | medium | 1 | 0 | aromatic ether | |
bupranolol | [no description available] | medium | 1 | 0 | aromatic ether | |
butalbital | [no description available] | medium | 1 | 0 | barbiturates | analgesic; sedative |
metrizoate | [no description available] | medium | 1 | 0 | monocarboxylic acid | radioopaque medium |
carbazochrome | [no description available] | medium | 1 | 0 | | |
carbinoxamine | [no description available] | medium | 1 | 0 | monochlorobenzenes; pyridines; tertiary amino compound | anti-allergic agent; antiparkinson drug; H1-receptor antagonist; muscarinic antagonist |
carmustine | [no description available] | medium | 1 | 0 | N-nitrosoureas; organochlorine compound | alkylating agent; antineoplastic agent |
chlorothiazide | [no description available] | medium | 1 | 0 | benzothiadiazine | antihypertensive agent; diuretic |
chloroxine | [no description available] | medium | 1 | 0 | monohydroxyquinoline; organochlorine compound | antibacterial agent; antifungal drug; antiseborrheic |
chlorpropamide | [no description available] | medium | 1 | 0 | monochlorobenzenes; N-sulfonylurea | hypoglycemic agent; insulin secretagogue |
clioquinol | [no description available] | medium | 1 | 0 | monohydroxyquinoline; organochlorine compound; organoiodine compound | antibacterial agent; antifungal agent; antimicrobial agent; antineoplastic agent; antiprotozoal drug; chelator; copper chelator |
clofazimine | [no description available] | medium | 1 | 0 | monochlorobenzenes; phenazines | dye; leprostatic drug; non-steroidal anti-inflammatory drug |
clonidine | [no description available] | medium | 5 | 0 | clonidine; imidazoline | |
cyclandelate | [no description available] | medium | 1 | 0 | carboxylic ester; secondary alcohol | vasodilator agent |
cyclofenil | [no description available] | medium | 1 | 0 | organic molecular entity | |
debrisoquin | [no description available] | medium | 1 | 0 | carboxamidine; isoquinolines | adrenergic agent; antihypertensive agent; human metabolite; sympatholytic agent |
amphetamine | [no description available] | medium | 15 | 0 | primary amine | |
dichlorphenamide | [no description available] | medium | 1 | 0 | dichlorobenzene; sulfonamide | antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor; ophthalmology drug |
disopyramide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; pyridines; tertiary amino compound | anti-arrhythmia drug |
valproic acid | [no description available] | medium | 3 | 0 | branched-chain fatty acid; branched-chain saturated fatty acid | anticonvulsant; antimanic drug; EC 3.5.1.98 (histone deacetylase) inhibitor; GABA agent; neuroprotective agent; psychotropic drug; teratogenic agent |
doxylamine | [no description available] | medium | 1 | 0 | pyridines; tertiary amine | anti-allergic agent; antiemetic; antitussive; cholinergic antagonist; H1-receptor antagonist; histamine antagonist; sedative |
dyphylline | [no description available] | medium | 1 | 0 | oxopurine; propane-1,2-diols | bronchodilator agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; muscle relaxant; vasodilator agent |
profenamine | [no description available] | medium | 1 | 0 | phenothiazines; tertiary amino compound | adrenergic antagonist; antidyskinesia agent; antiparkinson drug; histamine antagonist; muscarinic antagonist |
etizolam | [no description available] | medium | 1 | 0 | organic molecular entity | |
brl 42810 | [no description available] | medium | 1 | 0 | 2-aminopurines; acetate ester | antiviral drug; prodrug |
fenoprofen | [no description available] | medium | 1 | 0 | monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
berotek | [no description available] | medium | 2 | 0 | resorcinols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent; tocolytic agent |
flavoxate | [no description available] | medium | 1 | 0 | carboxylic ester; flavones; piperidines; tertiary amino compound | antispasmodic drug; muscarinic antagonist; parasympatholytic |
flecainide | [no description available] | medium | 2 | 0 | aromatic ether; monocarboxylic acid amide; organofluorine compound; piperidines | anti-arrhythmia drug |
flucytosine | [no description available] | medium | 1 | 0 | aminopyrimidine; nucleoside analogue; organofluorine compound; pyrimidine antifungal drug; pyrimidone | prodrug |
fluorouracil | [no description available] | medium | 1 | 0 | nucleobase analogue; organofluorine compound | antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic |
fluphenazine depot | [no description available] | medium | 1 | 0 | decanoate ester; N-alkylpiperazine; organofluorine compound; phenothiazines | dopaminergic antagonist; phenothiazine antipsychotic drug; prodrug |
fluphenazine enanthate | [no description available] | medium | 1 | 0 | phenothiazines | |
flurazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; monofluorobenzenes; organochlorine compound; tertiary amino compound | anticonvulsant; anxiolytic drug; GABAA receptor agonist; sedative |
flutazolam | [no description available] | medium | 1 | 0 | hemiaminal ether; organic molecular entity | |
furosemide | [no description available] | medium | 2 | 0 | chlorobenzoic acid; furans; sulfonamide | environmental contaminant; loop diuretic; xenobiotic |
gliclazide | [no description available] | medium | 1 | 0 | N-sulfonylurea | hypoglycemic agent; insulin secretagogue; radical scavenger |
guanethidine | [no description available] | medium | 2 | 0 | azocanes; guanidines | adrenergic antagonist; antihypertensive agent; sympatholytic agent |
hexylresorcinol | [no description available] | medium | 1 | 0 | resorcinols | |
hydralazine | [no description available] | medium | 1 | 0 | azaarene; hydrazines; ortho-fused heteroarene; phthalazines | antihypertensive agent; vasodilator agent |
hydroflumethiazide | [no description available] | medium | 1 | 0 | benzothiadiazine; thiazide | antihypertensive agent; diuretic |
amrinone | [no description available] | medium | 1 | 0 | bipyridines | EC 3.1.4.* (phosphoric diester hydrolase) inhibitor |
iodamide | [no description available] | medium | 1 | 0 | benzoic acids; organoiodine compound | radioopaque medium |
iothalamic acid | [no description available] | medium | 1 | 0 | organic molecular entity | |
iodipamide | [no description available] | medium | 1 | 0 | benzoic acids; organoiodine compound; secondary carboxamide | radioopaque medium |
isoniazid | [no description available] | medium | 1 | 0 | carbohydrazide | antitubercular agent; drug allergen |
isopropamide iodide | [no description available] | medium | 1 | 0 | diarylmethane | |
isoxsuprine | [no description available] | medium | 1 | 0 | alkylbenzene | |
ketotifen | [no description available] | medium | 1 | 0 | cyclic ketone; olefinic compound; organic heterotricyclic compound; organosulfur heterocyclic compound; piperidines; tertiary amino compound | anti-asthmatic drug; H1-receptor antagonist |
labetalol | [no description available] | medium | 2 | 0 | benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound | |
leflunomide | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; isoxazoles; monocarboxylic acid amide | antineoplastic agent; antiparasitic agent; EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; hepatotoxic agent; immunosuppressive agent; non-steroidal anti-inflammatory drug; prodrug; pyrimidine synthesis inhibitor; tyrosine kinase inhibitor |
loratadine | [no description available] | medium | 2 | 0 | benzocycloheptapyridine; ethyl ester; N-acylpiperidine; organochlorine compound; tertiary carboxamide | anti-allergic agent; cholinergic antagonist; geroprotector; H1-receptor antagonist |
lorazepam | [no description available] | medium | 1 | 0 | benzodiazepine | |
loxapine | [no description available] | medium | 1 | 0 | dibenzooxazepine | antipsychotic agent; dopaminergic antagonist |
memantine | [no description available] | medium | 2 | 0 | adamantanes; primary aliphatic amine | antidepressant; antiparkinson drug; dopaminergic agent; neuroprotective agent; NMDA receptor antagonist |
vitamin k 3 | [no description available] | medium | 2 | 0 | 1,4-naphthoquinones; vitamin K | angiogenesis inhibitor; antineoplastic agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; human urinary metabolite; nutraceutical |
mesoridazine | [no description available] | medium | 2 | 0 | phenothiazines; sulfoxide; tertiary amino compound | dopaminergic antagonist; first generation antipsychotic |
methocarbamol | [no description available] | medium | 1 | 0 | aromatic ether; carbamate ester; secondary alcohol | |
methyprylon | [no description available] | medium | 1 | 0 | organic molecular entity | |
metronidazole | [no description available] | medium | 1 | 0 | C-nitro compound; imidazoles; primary alcohol | antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic |
metyrapone | [no description available] | medium | 1 | 0 | aromatic ketone | antimetabolite; diagnostic agent; EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor |
midazolam | [no description available] | medium | 1 | 0 | imidazobenzodiazepine; monofluorobenzenes; organochlorine compound | anticonvulsant; antineoplastic agent; anxiolytic drug; apoptosis inducer; central nervous system depressant; GABAA receptor agonist; general anaesthetic; muscle relaxant; sedative |
modafinil | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; sulfoxide | |
moxisylyte | [no description available] | medium | 1 | 0 | monoterpenoid | |
nalidixic acid | [no description available] | medium | 4 | 0 | 1,8-naphthyridine derivative; monocarboxylic acid; quinolone antibiotic | antibacterial drug; antimicrobial agent; DNA synthesis inhibitor |
nefazodone | [no description available] | medium | 1 | 0 | aromatic ether; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazoles | alpha-adrenergic antagonist; analgesic; antidepressant; serotonergic antagonist; serotonin uptake inhibitor |
nimetazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; GABA modulator; sedative |
nimodipine | [no description available] | medium | 1 | 0 | 2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester | antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent |
nitrazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; drug metabolite; GABA modulator; sedative |
nomifensine | [no description available] | medium | 6 | 0 | isoquinolines | dopamine uptake inhibitor |
ofloxacin | [no description available] | medium | 2 | 0 | 3-oxo monocarboxylic acid; N-arylpiperazine; N-methylpiperazine; organofluorine compound; oxazinoquinoline | |
omeprazole | [no description available] | medium | 1 | 0 | aromatic ether; benzimidazoles; pyridines; sulfoxide | |
oxamniquine | [no description available] | medium | 1 | 0 | aromatic primary alcohol; C-nitro compound; quinolines; secondary amino compound | |
oxolinic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; organic heterotricyclic compound; oxacycle; quinolinemonocarboxylic acid; quinolone antibiotic | antibacterial drug; antifungal agent; antiinfective agent; antimicrobial agent; enzyme inhibitor |
pargyline | [no description available] | medium | 10 | 0 | aromatic amine | |
pentoxifylline | [no description available] | medium | 1 | 0 | oxopurine | |
perphenazine | [no description available] | medium | 2 | 0 | N-(2-hydroxyethyl)piperazine; N-alkylpiperazine; organochlorine compound; phenothiazines | antiemetic; dopaminergic antagonist; phenothiazine antipsychotic drug |
phenacemide | [no description available] | medium | 1 | 0 | acetamides | |
phenazopyridine | [no description available] | medium | 1 | 0 | diaminopyridine; monoazo compound | anticoronaviral agent; carcinogenic agent; local anaesthetic; non-narcotic analgesic |
phenindione | [no description available] | medium | 1 | 0 | aromatic ketone; beta-diketone | anticoagulant |
phenolphthalein | [no description available] | medium | 1 | 0 | phenols | |
phentermine | [no description available] | medium | 11 | 0 | primary amine | adrenergic agent; appetite depressant; central nervous system drug; central nervous system stimulant; dopaminergic agent; sympathomimetic agent |
pindolol | [no description available] | high | 2 | 0 | indoles; secondary amine | antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist; serotonergic antagonist; vasodilator agent |
pyranoprofen | [no description available] | medium | 1 | 0 | pyridochromene | |
probenecid | [no description available] | medium | 1 | 0 | benzoic acids; sulfonamide | uricosuric drug |
proglumide | [no description available] | medium | 1 | 0 | benzamides; dicarboxylic acid monoamide; glutamine derivative; racemate | anti-ulcer drug; cholecystokinin antagonist; cholinergic antagonist; delta-opioid receptor agonist; drug metabolite; gastrointestinal drug; opioid analgesic; xenobiotic metabolite |
propiomazine | [no description available] | medium | 1 | 0 | aromatic ketone; phenothiazines; tertiary amino compound | dopaminergic antagonist; histamine antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; sedative; serotonergic antagonist |
propranolol | [no description available] | medium | 8 | 0 | naphthalenes; propanolamine; secondary amine | anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic |
proxyphylline | [no description available] | medium | 1 | 0 | oxopurine | |
rizatriptan | [no description available] | medium | 1 | 0 | tryptamines | anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
rofecoxib | [no description available] | medium | 1 | 0 | butenolide; sulfone | analgesic; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
salicylsalicylic acid | [no description available] | medium | 1 | 0 | benzoate ester; benzoic acids; phenols; salicylates | antineoplastic agent; antirheumatic drug; EC 3.5.2.6 (beta-lactamase) inhibitor; hypoglycemic agent; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug |
ipodate | [no description available] | medium | 1 | 0 | | |
succinylcholine | [no description available] | medium | 1 | 0 | quaternary ammonium ion; succinate ester | drug allergen; muscle relaxant; neuromuscular agent |
sulfadimethoxine | [no description available] | medium | 1 | 0 | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic |
sulfamethoxazole | [no description available] | medium | 2 | 0 | isoxazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial agent; antiinfective agent; antimicrobial agent; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; epitope; P450 inhibitor; xenobiotic |
sulfobromophthalein | [no description available] | medium | 1 | 0 | 2-benzofurans; organobromine compound; organosulfonic acid; phenols | dye |
sumatriptan | [no description available] | medium | 2 | 0 | sulfonamide; tryptamines | serotonergic agonist; vasoconstrictor agent |
terazosin | [no description available] | medium | 1 | 0 | furans; piperazines; primary amino compound; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; antineoplastic agent |
terbutaline | [no description available] | medium | 1 | 0 | phenylethanolamines; resorcinols | anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; hypoglycemic agent; sympathomimetic agent; tocolytic agent |
thalidomide | [no description available] | medium | 1 | 0 | phthalimides; piperidones | |
tiaramide | [no description available] | medium | 1 | 0 | benzothiazoles | |
ticlopidine | [no description available] | medium | 1 | 0 | monochlorobenzenes; thienopyridine | anticoagulant; fibrin modulating drug; hematologic agent; P2Y12 receptor antagonist; platelet aggregation inhibitor |
tiopronin | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
tizanidine | [no description available] | medium | 1 | 0 | benzothiadiazole; imidazoles | alpha-adrenergic agonist; muscle relaxant |
tolperisone | [no description available] | medium | 1 | 0 | aromatic ketone | |
ultram | [no description available] | medium | 1 | 0 | aromatic ether; tertiary alcohol; tertiary amino compound | |
trichlormethiazide | [no description available] | medium | 1 | 0 | benzothiadiazine; sulfonamide antibiotic | antihypertensive agent; diuretic |
trifluperidol | [no description available] | medium | 1 | 0 | aromatic ketone | |
trimebutine | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
trimethadione | [no description available] | medium | 1 | 0 | oxazolidinone | anticonvulsant; geroprotector |
trimethoprim | [no description available] | medium | 1 | 0 | aminopyrimidine; methoxybenzenes | antibacterial drug; diuretic; drug allergen; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; environmental contaminant; xenobiotic |
trimipramine | [no description available] | medium | 3 | 0 | dibenzoazepine; tertiary amino compound | antidepressant; environmental contaminant; xenobiotic |
tripelennamine | [no description available] | medium | 2 | 0 | aromatic amine | |
troglitazone | [no description available] | medium | 1 | 0 | chromanes; thiazolidinone | anticoagulant; anticonvulsant; antineoplastic agent; antioxidant; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; hypoglycemic agent; platelet aggregation inhibitor; vasodilator agent |
delavirdine | [no description available] | medium | 1 | 0 | aminopyridine; indolecarboxamide; N-acylpiperazine; sulfonamide | antiviral drug; HIV-1 reverse transcriptase inhibitor |
venlafaxine | [no description available] | medium | 1 | 0 | cyclohexanols; monomethoxybenzene; tertiary alcohol; tertiary amino compound | adrenergic uptake inhibitor; analgesic; antidepressant; dopamine uptake inhibitor; environmental contaminant; serotonin uptake inhibitor; xenobiotic |
lysergic acid diethylamide | [no description available] | medium | 2 | 0 | ergoline alkaloid; monocarboxylic acid amide; organic heterotetracyclic compound | dopamine agonist; hallucinogen; serotonergic agonist |
sorbitol | [no description available] | medium | 1 | 0 | glucitol | cathartic; Escherichia coli metabolite; food humectant; human metabolite; laxative; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite; sweetening agent |
floxuridine | [no description available] | medium | 1 | 0 | nucleoside analogue; organofluorine compound; pyrimidine 2'-deoxyribonucleoside | antimetabolite; antineoplastic agent; antiviral drug; radiosensitizing agent |
norethindrone acetate | [no description available] | medium | 1 | 0 | 3-oxo-Delta(4) steroid; acetate ester; terminal acetylenic compound | progestin; synthetic oral contraceptive |
cyclobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
norethandrolone | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
oxandrolone | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3-oxo steroid; anabolic androgenic steroid; oxa-steroid | anabolic agent; androgen |
pilocarpine | [no description available] | medium | 1 | 0 | pilocarpine | antiglaucoma drug |
desoxycorticosterone acetate | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
chloramphenicol | [no description available] | medium | 3 | 0 | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor |
lysine | [no description available] | medium | 1 | 0 | aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid | algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
cysteamine | [no description available] | medium | 1 | 0 | amine; thiol | geroprotector; human metabolite; mouse metabolite; radiation protective agent |
bretylium tosylate | [no description available] | medium | 1 | 0 | organosulfonate salt; quaternary ammonium salt | adrenergic antagonist; anti-arrhythmia drug; antihypertensive agent |
leucine | [no description available] | medium | 2 | 0 | amino acid zwitterion; L-alpha-amino acid; leucine; proteinogenic amino acid; pyruvate family amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
gallamine triethiodide | [no description available] | medium | 1 | 0 | | |
cytarabine | [no description available] | medium | 1 | 0 | beta-D-arabinoside; monosaccharide derivative; pyrimidine nucleoside | antimetabolite; antineoplastic agent; antiviral agent; immunosuppressive agent |
4-hydroxypropiophenone | [no description available] | medium | 1 | 0 | acetophenones | |
methandrostenolone | [no description available] | medium | 1 | 0 | organic molecular entity | |
quinethazone | [no description available] | medium | 1 | 0 | quinazolines | antihypertensive agent; diuretic |
tribromoethanol | [no description available] | medium | 1 | 0 | alcohol; organobromine compound | |
mepenzolate bromide | [no description available] | medium | 1 | 0 | diarylmethane | |
carbromal | [no description available] | medium | 1 | 0 | N-acylurea | |
pantothenic acid | [no description available] | medium | 1 | 0 | pantothenic acid; vitamin B5 | antidote to curare poisoning; geroprotector; human blood serum metabolite |
buclizine | [no description available] | medium | 1 | 0 | monochlorobenzenes; N-alkylpiperazine | antiemetic; central nervous system depressant; cholinergic antagonist; histamine antagonist; local anaesthetic |
thiopropazate | [no description available] | medium | 1 | 0 | acetate ester; N-alkylpiperazine; organochlorine compound; phenothiazines | dopaminergic antagonist; phenothiazine antipsychotic drug |
acetrizoic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid | |
penicillin v | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | |
pseudoephedrine | [no description available] | medium | 1 | 0 | phenylethanolamines; secondary alcohol; secondary amino compound | anti-asthmatic drug; bronchodilator agent; central nervous system drug; nasal decongestant; plant metabolite; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
propylparaben | [no description available] | medium | 1 | 0 | benzoate ester; paraben; phenols | antifungal agent; antimicrobial agent |
methylparaben | [no description available] | medium | 1 | 0 | paraben | antifungal agent; antimicrobial food preservative; neuroprotective agent; plant metabolite |
estradiol dipropionate | [no description available] | medium | 1 | 0 | steroid ester | |
paramethadione | [no description available] | medium | 1 | 0 | oxazolidinone | anticonvulsant |
framycetin | [no description available] | medium | 1 | 0 | aminoglycoside | allergen; antibacterial drug; Escherichia coli metabolite |
anileridine | [no description available] | medium | 1 | 0 | ethyl ester; piperidinecarboxylate ester; substituted aniline | opioid analgesic; opioid receptor agonist |
ditiocarb | [no description available] | medium | 1 | 0 | dithiocarbamic acids | chelator; copper chelator |
sulfalene | [no description available] | medium | 1 | 0 | pyrazines; sulfonamide antibiotic; sulfonamide | |
propantheline bromide | [no description available] | medium | 1 | 0 | xanthenes | |
ephedrine | [no description available] | medium | 1 | 0 | phenethylamine alkaloid; phenylethanolamines | bacterial metabolite; environmental contaminant; nasal decongestant; plant metabolite; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
chlormadinone acetate | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
evans blue | [no description available] | medium | 1 | 0 | organic sodium salt | fluorochrome; histological dye; sodium channel blocker; teratogenic agent |
opipramol | [no description available] | medium | 4 | 0 | dibenzoazepine | |
carbutamide | [no description available] | medium | 1 | 0 | benzenes; sulfonamide | |
glymidine | [no description available] | medium | 1 | 0 | diether; pyrimidines; sulfonamide | hypoglycemic agent |
nandrolone | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; anabolic androgenic steroid | human metabolite |
thiazolidine-4-carboxylic acid | [no description available] | medium | 1 | 0 | alpha-amino acid zwitterion; non-proteinogenic alpha-amino acid; sulfur-containing amino acid; thiazolidinemonocarboxylic acid | antidote; antioxidant; hepatoprotective agent |
dextropropoxyphene | [no description available] | medium | 1 | 0 | 1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate | mu-opioid receptor agonist; opioid analgesic |
lucanthone | [no description available] | medium | 1 | 0 | thioxanthenes | adjuvant; antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; mutagen; photosensitizing agent; prodrug; schistosomicide drug |
dichloralantipyrine | [no description available] | medium | 1 | 0 | | |
dihydralazine | [no description available] | medium | 1 | 0 | phthalazines | |
methallenestril | [no description available] | medium | 1 | 0 | naphthalenes | |
androstenediol | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid | androgen; human metabolite; mouse metabolite; radiation protective agent |
levocarnitine | [no description available] | medium | 1 | 0 | carnitine | antilipemic drug; nootropic agent; nutraceutical; Saccharomyces cerevisiae metabolite; water-soluble vitamin (role) |
decamethonium dibromide | [no description available] | medium | 1 | 0 | | |
thiphenamil | [no description available] | medium | 1 | 0 | diarylmethane | |
metahexamide | [no description available] | medium | 1 | 0 | benzenes; sulfonamide | |
phenindamine | [no description available] | medium | 1 | 0 | indene | |
2-amino-2-methyl-1-propanol | [no description available] | medium | 1 | 0 | | |
phendimetrazine | [no description available] | medium | 1 | 0 | | |
trimetozine | [no description available] | medium | 1 | 0 | morpholines | |
butaperazine | [no description available] | medium | 1 | 0 | phenothiazines | |
vinblastine | [no description available] | medium | 2 | 0 | | |
oxolamine | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
ethylestrenol | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; tertiary alcohol | anabolic agent |
dehydroepiandrosterone acetate | [no description available] | medium | 1 | 0 | steroid ester | |
metaxalone | [no description available] | medium | 1 | 0 | aromatic ether | |
spectinomycin | [no description available] | medium | 2 | 0 | cyclic acetal; cyclic hemiketal; cyclic ketone; pyranobenzodioxin; secondary alcohol; secondary amino compound | antibacterial drug; antimicrobial agent; bacterial metabolite |
clothiapine | [no description available] | medium | 1 | 0 | dibenzothiazepine | |
azaribine | [no description available] | medium | 1 | 0 | acetate ester; N-glycosyl-1,2,4-triazine | antipsoriatic; prodrug |
sulfadoxine | [no description available] | medium | 1 | 0 | pyrimidines; sulfonamide | antibacterial drug; antimalarial |
acetophenazine | [no description available] | medium | 1 | 0 | N-(2-hydroxyethyl)piperazine; N-alkylpiperazine; phenothiazines | phenothiazine antipsychotic drug |
cephaloglycin | [no description available] | medium | 1 | 0 | beta-lactam antibiotic allergen; cephalosporin | antimicrobial agent |
streptomycin | [no description available] | medium | 2 | 0 | antibiotic antifungal drug; antibiotic fungicide; streptomycins | antibacterial drug; antifungal agrochemical; antimicrobial agent; antimicrobial drug; bacterial metabolite; protein synthesis inhibitor |
noxiptilin | [no description available] | medium | 2 | 0 | organic tricyclic compound | |
benorilate | [no description available] | medium | 1 | 0 | carbonyl compound | |
metocurine | [no description available] | medium | 1 | 0 | isoquinolines | |
floxacillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
isometheptene | [no description available] | medium | 1 | 0 | secondary amino compound | |
olsalazine | [no description available] | medium | 1 | 0 | azobenzenes; dicarboxylic acid | non-steroidal anti-inflammatory drug; prodrug |
molindone | [no description available] | medium | 1 | 0 | indoles | |
hexocyclium | [no description available] | medium | 1 | 0 | amine | |
ancitabine | [no description available] | medium | 1 | 0 | diol; organic heterotricyclic compound | antimetabolite; antineoplastic agent; prodrug |
clortermine | [no description available] | medium | 1 | 0 | amphetamines | |
nicofuranose | [no description available] | medium | 1 | 0 | organooxygen compound | |
apazone | [no description available] | medium | 1 | 0 | benzotriazines | non-steroidal anti-inflammatory drug; uricosuric drug |
cloforex | [no description available] | medium | 2 | 0 | amphetamines | |
selegiline | [no description available] | medium | 1 | 0 | selegiline; terminal acetylenic compound | geroprotector |
levamisole | [no description available] | medium | 1 | 0 | 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole | antinematodal drug; antirheumatic drug; EC 3.1.3.1 (alkaline phosphatase) inhibitor; immunological adjuvant; immunomodulator |
clobutinol | [no description available] | medium | 1 | 0 | benzenes; organic amino compound | |
thiamphenicol | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; sulfone | antimicrobial agent; immunosuppressive agent |
isosorbide-5-mononitrate | [no description available] | medium | 1 | 0 | glucitol derivative; nitrate ester | nitric oxide donor; vasodilator agent |
razoxane | [no description available] | medium | 1 | 0 | N-alkylpiperazine | |
fludarabine phosphate | [no description available] | medium | 1 | 0 | nucleoside analogue; organofluorine compound; purine arabinonucleoside monophosphate | antimetabolite; antineoplastic agent; antiviral agent; DNA synthesis inhibitor; immunosuppressive agent; prodrug |
proquazone | [no description available] | medium | 1 | 0 | pyrimidines | |
halazepam | [no description available] | medium | 1 | 0 | organic molecular entity | |
ripazepam | [no description available] | medium | 1 | 0 | benzenes | |
amoxicillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
moricizine | [no description available] | medium | 2 | 0 | carbamate ester; morpholines; phenothiazines | anti-arrhythmia drug |
feprazone | [no description available] | medium | 1 | 0 | organic molecular entity | |
halofantrine | [no description available] | medium | 1 | 0 | phenanthrenes | |
ribavirin | [no description available] | medium | 1 | 0 | 1-ribosyltriazole; aromatic amide; monocarboxylic acid amide; primary carboxamide | anticoronaviral agent; antiinfective agent; antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
epirubicin | [no description available] | medium | 1 | 0 | aminoglycoside; anthracycline antibiotic; anthracycline; deoxy hexoside; monosaccharide derivative; p-quinones; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | antimicrobial agent; antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
prenalterol | [no description available] | medium | 2 | 0 | aromatic ether | |
lorcainide | [no description available] | medium | 1 | 0 | acetamides | |
idarubicin | [no description available] | medium | 1 | 0 | anthracycline antibiotic; deoxy hexoside; monosaccharide derivative | |
atracurium | [no description available] | medium | 1 | 0 | diester; quaternary ammonium ion | muscle relaxant; nicotinic antagonist |
pergolide | [no description available] | medium | 1 | 0 | diamine; methyl sulfide; organic heterotetracyclic compound | antiparkinson drug; dopamine agonist |
doxofylline | [no description available] | medium | 1 | 0 | oxopurine | anti-asthmatic drug; antitussive; bronchodilator agent |
alfentanil | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; piperidines | central nervous system depressant; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic; peripheral nervous system drug |
cefotetan | [no description available] | medium | 1 | 0 | | |
quinapril | [no description available] | medium | 1 | 0 | dicarboxylic acid monoester; ethyl ester; isoquinolines; tertiary carboxamide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; prodrug |
esmolol | [no description available] | medium | 1 | 0 | aromatic ether; ethanolamines; methyl ester; secondary alcohol; secondary amino compound | |
tiagabine | [no description available] | medium | 1 | 0 | beta-amino acid; piperidinemonocarboxylic acid; tertiary amino compound; thiophenes | anticonvulsant; GABA reuptake inhibitor |
lamivudine | [no description available] | medium | 1 | 0 | monothioacetal; nucleoside analogue; oxacycle; primary alcohol | allergen; anti-HBV agent; antiviral drug; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor; HIV-1 reverse transcriptase inhibitor; prodrug |
ziprasidone | [no description available] | medium | 1 | 0 | 1,2-benzisothiazole; indolones; organochlorine compound; piperazines | antipsychotic agent; dopaminergic antagonist; histamine antagonist; muscarinic antagonist; psychotropic drug; serotonergic antagonist |
adenosine | [no description available] | medium | 2 | 0 | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
ceftezole | [no description available] | medium | 1 | 0 | cephalosporin; thiadiazoles | |
sertraline | [no description available] | medium | 2 | 0 | dichlorobenzene; secondary amino compound; tetralins | antidepressant; serotonin uptake inhibitor |
dipropylacetamide | [no description available] | medium | 1 | 0 | fatty amide | geroprotector; metabolite; teratogenic agent |
clociguanil | [no description available] | medium | 2 | 0 | | |
lividomycin | [no description available] | medium | 1 | 0 | lividomycins | metabolite |
gentamicin c1 | [no description available] | medium | 2 | 0 | | |
clarithromycin | [no description available] | medium | 2 | 0 | macrolide antibiotic | antibacterial drug; environmental contaminant; protein synthesis inhibitor; xenobiotic |
moexipril | [no description available] | medium | 1 | 0 | peptide | |
sennoside B | [no description available] | medium | 1 | 0 | oxo dicarboxylic acid; sennosides | |
dimethacrine | [no description available] | medium | 1 | 0 | acridines | |
perindopril | [no description available] | medium | 1 | 0 | alpha-amino acid ester; dicarboxylic acid monoester; ethyl ester; organic heterobicyclic compound | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
5-hydroxydopamine | [no description available] | medium | 2 | 0 | catecholamine | |
tazobactam | [no description available] | medium | 1 | 0 | penicillanic acids; triazoles | antiinfective agent; antimicrobial agent; EC 3.5.2.6 (beta-lactamase) inhibitor |
xylose | [no description available] | medium | 1 | 0 | D-xylose | |
levofloxacin | [no description available] | medium | 2 | 0 | 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; fluoroquinolone antibiotic; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
clofibride | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
aminopterin | [no description available] | medium | 1 | 0 | dicarboxylic acid | EC 1.5.1.3 (dihydrofolate reductase) inhibitor; mutagen |
l 694,458 | [no description available] | medium | 2 | 0 | | |
carbocysteine | [no description available] | medium | 1 | 0 | L-cysteine thioether; non-proteinogenic L-alpha-amino acid | mucolytic |
dromostanolone propionate | [no description available] | medium | 1 | 0 | 3-oxo-5alpha-steroid; steroid ester | antineoplastic agent |
phenethicillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | |
bekanamycin | [no description available] | medium | 1 | 0 | kanamycins | |
griseofulvin | [no description available] | medium | 1 | 0 | 1-benzofurans; antibiotic antifungal drug; benzofuran antifungal drug; organochlorine compound; oxaspiro compound | antibacterial agent; Penicillium metabolite |
hetacillin | [no description available] | medium | 1 | 0 | penicillin | antibacterial drug |
medigoxin | [no description available] | medium | 1 | 0 | cardenolide glycoside | |
betamethasone acetate | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 3-oxo-Delta(1),Delta(4)-steroid; acetate ester; fluorinated steroid; steroid ester; tertiary alpha-hydroxy ketone | |
retinol | [no description available] | medium | 1 | 0 | retinol; vitamin A | human metabolite; mouse metabolite; plant metabolite |
zithromax | [no description available] | medium | 2 | 0 | macrolide antibiotic | antibacterial drug; environmental contaminant; xenobiotic |
melphalan | [no description available] | medium | 1 | 0 | L-phenylalanine derivative; nitrogen mustard; non-proteinogenic L-alpha-amino acid; organochlorine compound | alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent |
riboflavin | [no description available] | medium | 1 | 0 | flavin; vitamin B2 | anti-inflammatory agent; antioxidant; cofactor; Escherichia coli metabolite; food colouring; fundamental metabolite; human urinary metabolite; mouse metabolite; photosensitizing agent; plant metabolite |
flavin mononucleotide | [no description available] | medium | 1 | 0 | flavin mononucleotide; vitamin B2 | bacterial metabolite; coenzyme; cofactor; human metabolite; mouse metabolite |
mezlocillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
mitobronitol | [no description available] | medium | 1 | 0 | alcohol; organobromine compound | |
prednisolone hemisuccinate | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 3-oxo-Delta(1),Delta(4)-steroid; hemisuccinate; tertiary alpha-hydroxy ketone | anti-inflammatory drug |
octotropine methylbromide | [no description available] | medium | 1 | 0 | | |
nsc 4347 | [no description available] | medium | 1 | 0 | | |
etomidate | [no description available] | medium | 1 | 0 | ethyl ester; imidazoles | intravenous anaesthetic; sedative |
mercaptopurine | [no description available] | medium | 1 | 0 | aryl thiol; purines; thiocarbonyl compound | anticoronaviral agent; antimetabolite; antineoplastic agent |
lobeline | [no description available] | medium | 1 | 0 | | |
benztropine | [no description available] | medium | 1 | 0 | diarylmethane | |
thiouracil | [no description available] | medium | 1 | 0 | nucleobase analogue; thiocarbonyl compound | antithyroid drug; metabolite |
terbinafine | [no description available] | medium | 1 | 0 | acetylenic compound; allylamine antifungal drug; enyne; naphthalenes; tertiary amine | EC 1.14.13.132 (squalene monooxygenase) inhibitor; P450 inhibitor; sterol biosynthesis inhibitor |
1,4-benzoquinone guanylhydrazone thiosemicarbazone | [no description available] | medium | 1 | 0 | | |
digoxin | [no description available] | medium | 1 | 0 | cardenolide glycoside; steroid saponin | anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; epitope |
zeranol | [no description available] | medium | 1 | 0 | macrolide | |
thiopental | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant; drug allergen; environmental contaminant; intravenous anaesthetic; sedative; xenobiotic |
toremifene | [no description available] | medium | 1 | 0 | aromatic ether; organochlorine compound; tertiary amine | antineoplastic agent; bone density conservation agent; estrogen antagonist; estrogen receptor modulator |
albutoin | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
iodothiouracil | [no description available] | medium | 1 | 0 | organohalogen compound; pyrimidines | |
tolcapone | [no description available] | medium | 1 | 0 | 2-nitrophenols; benzophenones; catechols | antiparkinson drug; EC 2.1.1.6 (catechol O-methyltransferase) inhibitor |
bilirubin | [no description available] | medium | 2 | 0 | biladienes; dicarboxylic acid | antioxidant; human metabolite; mouse metabolite |
dinoprost | [no description available] | medium | 1 | 0 | monocarboxylic acid; prostaglandins Falpha | human metabolite; mouse metabolite |
calcitriol | [no description available] | medium | 1 | 0 | D3 vitamins; hydroxycalciol; triol | antineoplastic agent; antipsoriatic; bone density conservation agent; calcium channel agonist; calcium channel modulator; hormone; human metabolite; immunomodulator; metabolite; mouse metabolite; nutraceutical |
beta carotene | [no description available] | medium | 1 | 0 | carotenoid beta-end derivative; cyclic carotene | antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A |
clavulanic acid | [no description available] | medium | 1 | 0 | oxapenam | antibacterial drug; anxiolytic drug; bacterial metabolite; EC 3.5.2.6 (beta-lactamase) inhibitor |
eprosartan | [no description available] | medium | 1 | 0 | dicarboxylic acid; imidazoles; thiophenes | angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic |
ethchlorvynol | [no description available] | medium | 1 | 0 | | |
rokitamycin | [no description available] | medium | 1 | 0 | organic molecular entity | |
etretinate | [no description available] | medium | 1 | 0 | enoate ester; ethyl ester; retinoid | keratolytic drug |
misoprostol | [no description available] | medium | 1 | 0 | | |
epoprostenol | [no description available] | medium | 1 | 0 | prostaglandins I | mouse metabolite |
triprolidine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine; olefinic compound; pyridines | H1-receptor antagonist |
natamycin | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; dicarboxylic acid monoester; epoxide; macrolide antibiotic; monosaccharide derivative; polyene antibiotic | antifungal agrochemical; antimicrobial food preservative; apoptosis inducer; bacterial metabolite; ophthalmology drug |
cloprednol | [no description available] | medium | 1 | 0 | 21-hydroxy steroid | |
cyproterone | [no description available] | medium | 1 | 0 | 17alpha-hydroxy steroid; 20-oxo steroid; 3-oxo-Delta(4) steroid; chlorinated steroid; tertiary alpha-hydroxy ketone | androgen antagonist |
estropipate | [no description available] | medium | 1 | 0 | piperazinium salt; steroid sulfate | |
hydroxystilbamidine | [no description available] | medium | 1 | 0 | | |
levetiracetam | [no description available] | medium | 1 | 0 | pyrrolidin-2-ones | anticonvulsant; environmental contaminant; xenobiotic |
meprednisone | [no description available] | medium | 1 | 0 | 21-hydroxy steroid | |
oxymorphone | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
acepreval | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
proscillaridin | [no description available] | medium | 1 | 0 | organic molecular entity | |
fluvoxamine | [no description available] | medium | 2 | 0 | (trifluoromethyl)benzenes; 5-methoxyvalerophenone O-(2-aminoethyl)oxime | antidepressant; anxiolytic drug; serotonin uptake inhibitor |
butorphanol | [no description available] | medium | 1 | 0 | morphinane alkaloid | antitussive; kappa-opioid receptor agonist; mu-opioid receptor agonist; opioid analgesic |
cefixime | [no description available] | medium | 1 | 0 | cephalosporin | antibacterial drug; drug allergen |
ceftriaxone | [no description available] | medium | 1 | 0 | 1,2,4-triazines; 1,3-thiazoles; cephalosporin; oxime O-ether | antibacterial drug; drug allergen; EC 3.5.2.6 (beta-lactamase) inhibitor |
trandolapril | [no description available] | medium | 1 | 0 | dicarboxylic acid monoester; dipeptide; ethyl ester; organic heterobicyclic compound; secondary amino compound; tertiary carboxamide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; prodrug |
nitrofurantoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione; nitrofuran antibiotic; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic | antibacterial drug; antiinfective agent; hepatotoxic agent |
fosinopril | [no description available] | medium | 1 | 0 | | |
abt-770 | [no description available] | medium | 2 | 0 | | |
9-n-(1-propyl)erythromyclamine | [no description available] | medium | 2 | 0 | | |
homatropine methylbromide | [no description available] | medium | 1 | 0 | | |
vindesine | [no description available] | medium | 1 | 0 | | |
novobiocin | [no description available] | medium | 1 | 0 | carbamate ester; ether; hexoside; hydroxycoumarin; monocarboxylic acid amide; monosaccharide derivative; phenols | antibacterial agent; antimicrobial agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Escherichia coli metabolite; hepatoprotective agent |
tetracycline | [no description available] | medium | 2 | 0 | | |
warfarin | [no description available] | medium | 1 | 0 | benzenes; hydroxycoumarin; methyl ketone | |
bephenium hydroxynaphthoate | [no description available] | medium | 1 | 0 | | |
phenprocoumon | [no description available] | medium | 1 | 0 | hydroxycoumarin | anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor |
folic acid | [no description available] | medium | 1 | 0 | folic acids; N-acyl-amino acid | human metabolite; mouse metabolite; nutrient |
viomycin | [no description available] | medium | 1 | 0 | heterodetic cyclic peptide; peptide antibiotic | antitubercular agent |
dacarbazine | [no description available] | medium | 1 | 0 | dacarbazine | |
olanzapine | [no description available] | medium | 1 | 0 | benzodiazepine; N-arylpiperazine; N-methylpiperazine | antiemetic; dopaminergic antagonist; histamine antagonist; muscarinic antagonist; second generation antipsychotic; serotonergic antagonist; serotonin uptake inhibitor |
allopurinol | [no description available] | medium | 2 | 0 | nucleobase analogue; organic heterobicyclic compound | antimetabolite; EC 1.17.3.2 (xanthine oxidase) inhibitor; gout suppressant; radical scavenger |
trospectomycin | [no description available] | medium | 2 | 0 | dioxanes | |
bts 54 524 | [no description available] | medium | 1 | 0 | | |
methoxyhydroxyphenylglycol | [no description available] | medium | 4 | 0 | methoxybenzenes; phenols | |
s-adenosylmethionine | [no description available] | medium | 1 | 0 | organic cation; sulfonium compound | coenzyme; cofactor; human metabolite; micronutrient; Mycoplasma genitalium metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
carbachol | [no description available] | medium | 1 | 0 | ammonium salt; carbamate ester | cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic |
sulpiride | [no description available] | medium | 1 | 0 | benzamides; N-alkylpyrrolidine; sulfonamide | antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist |
dextroamphetamine | [no description available] | medium | 13 | 0 | 1-phenylpropan-2-amine | adrenergic agent; adrenergic uptake inhibitor; dopamine uptake inhibitor; dopaminergic agent; neurotoxin; sympathomimetic agent |
alpha-methyl-m-tyrosine | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
thiourea | [no description available] | medium | 1 | 0 | one-carbon compound; thioureas; ureas | antioxidant; chromophore |
dimaprit | [no description available] | medium | 1 | 0 | imidothiocarbamic ester | |
hydroxyindoleacetic acid | [no description available] | medium | 7 | 0 | indole-3-acetic acids | drug metabolite; human metabolite; mouse metabolite |
thyroxine | [no description available] | medium | 1 | 0 | 2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine | antithyroid drug; human metabolite; mouse metabolite; thyroid hormone |
methamphetamine | [no description available] | medium | 4 | 0 | amphetamines; secondary amine | central nervous system stimulant; environmental contaminant; neurotoxin; psychotropic drug; xenobiotic |
tryptophan | [no description available] | medium | 3 | 0 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan | antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
lithium | [no description available] | medium | 6 | 1 | alkali metal atom | |
pyridoxine | [no description available] | medium | 1 | 0 | hydroxymethylpyridine; methylpyridines; monohydroxypyridine; vitamin B6 | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
orphenadrine | [no description available] | medium | 2 | 0 | ether; tertiary amino compound | antidyskinesia agent; antiparkinson drug; H1-receptor antagonist; muscarinic antagonist; muscle relaxant; NMDA receptor antagonist; parasympatholytic |
viloxazine | [no description available] | medium | 5 | 0 | aromatic ether | |
flupenthixol | [no description available] | medium | 1 | 0 | thioxanthenes | |
tofenacin | [no description available] | medium | 1 | 0 | diarylmethane | |
alprenolol | [no description available] | medium | 2 | 0 | secondary alcohol; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
dihydroalprenolol | [no description available] | medium | 3 | 0 | | |
glucose, (beta-d)-isomer | [no description available] | medium | 1 | 0 | D-glucopyranose | epitope; mouse metabolite |
phenylephrine | [no description available] | medium | 2 | 0 | phenols; phenylethanolamines; secondary amino compound | alpha-adrenergic agonist; cardiotonic drug; mydriatic agent; nasal decongestant; protective agent; sympathomimetic agent; vasoconstrictor agent |
ouabain | [no description available] | medium | 3 | 0 | 11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone | anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite |
neostigmine | [no description available] | medium | 1 | 0 | quaternary ammonium ion | antidote to curare poisoning; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
sulforidazine | [no description available] | medium | 1 | 0 | phenothiazines | |
melatonin | [no description available] | medium | 1 | 0 | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger |
n-acetylserotonin | [no description available] | medium | 1 | 0 | acetamides; N-acylserotonin; phenols | antioxidant; human metabolite; mouse metabolite; tropomyosin-related kinase B receptor agonist |
piperidines | [no description available] | medium | 2 | 0 | | |
ketanserin | [no description available] | medium | 2 | 0 | aromatic ketone; organofluorine compound; piperidines; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; cardiovascular drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; serotonergic antagonist |
nisoxetine | [no description available] | medium | 2 | 0 | aromatic ether; secondary amino compound | adrenergic uptake inhibitor; antidepressant |
corticosterone | [no description available] | medium | 2 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite |
alpha-aminopyridine | [no description available] | medium | 1 | 0 | | |
org 6582 | [no description available] | medium | 1 | 0 | | |
5-hydroxytryptophan | [no description available] | medium | 2 | 0 | hydroxytryptophan | human metabolite; neurotransmitter |
methysergide | [no description available] | medium | 3 | 0 | ergoline alkaloid | |
nordefrin | [no description available] | medium | 1 | 0 | catecholamine | |
metaraminol | [no description available] | medium | 1 | 0 | phenylethanolamines | alpha-adrenergic agonist; sympathomimetic agent; vasoconstrictor agent |
amfonelic acid | [no description available] | medium | 3 | 0 | | |
3,4-dihydroxyphenylacetic acid | [no description available] | medium | 5 | 0 | catechols; dihydroxyphenylacetic acid | human metabolite |
homovanillic acid | [no description available] | medium | 5 | 0 | guaiacols; monocarboxylic acid | human metabolite; mouse metabolite |
apomorphine | [no description available] | medium | 3 | 0 | aporphine alkaloid | alpha-adrenergic drug; antidyskinesia agent; antiparkinson drug; dopamine agonist; emetic; serotonergic drug |
metergoline | [no description available] | medium | 1 | 0 | carbamate ester; ergoline alkaloid | dopamine agonist; geroprotector; serotonergic antagonist |
ergoline | [no description available] | medium | 1 | 0 | diamine; ergoline alkaloid; indole alkaloid fundamental parent; indole alkaloid; organic heterotetracyclic compound | |
p-chloroamphetamine | [no description available] | medium | 6 | 0 | | |
glutamic acid | [no description available] | medium | 1 | 0 | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
racemetirosine | [no description available] | medium | 1 | 0 | | |
xylazine | [no description available] | medium | 1 | 0 | 1,3-thiazine; methylbenzene; secondary amino compound | alpha-adrenergic agonist; analgesic; emetic; muscle relaxant; sedative |
oxotremorine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine | |
gamma-aminobutyric acid | [no description available] | medium | 1 | 0 | amino acid zwitterion; gamma-amino acid; monocarboxylic acid | human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule |
levodopa | [no description available] | medium | 2 | 0 | amino acid zwitterion; dopa; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | allelochemical; antidyskinesia agent; antiparkinson drug; dopaminergic agent; hapten; human metabolite; mouse metabolite; neurotoxin; plant growth retardant; plant metabolite; prodrug |
dibenzepin | [no description available] | medium | 1 | 0 | dibenzodiazepine | |
p-hydroxyamphetamine | [no description available] | medium | 1 | 0 | amphetamines | |
glutathione disulfide | [no description available] | medium | 1 | 0 | glutathione derivative; organic disulfide | Escherichia coli metabolite; mouse metabolite |
deoxyglucose | [no description available] | medium | 1 | 0 | | |
fenclonine | [no description available] | medium | 5 | 0 | phenylalanine derivative | |
tyrosine | [no description available] | medium | 3 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical |
phenylalanine | [no description available] | medium | 2 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
octopamine | [no description available] | medium | 2 | 0 | phenylethanolamines; tyramines | neurotransmitter |
(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride | [no description available] | medium | 1 | 0 | | |
dimethylphenylpiperazinium iodide | [no description available] | medium | 1 | 0 | N-arylpiperazine; organic iodide salt; piperazinium salt; quaternary ammonium salt | nicotinic acetylcholine receptor agonist |
dihydroxyphenylalanine | [no description available] | medium | 1 | 0 | hydroxyphenylalanine; non-proteinogenic alpha-amino acid; tyrosine derivative | human metabolite |
tyramine | [no description available] | medium | 2 | 1 | monoamine molecular messenger; primary amino compound; tyramines | EC 3.1.1.8 (cholinesterase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter |
benserazide | [no description available] | medium | 1 | 0 | carbohydrazide; catechols; primary alcohol; primary amino compound | antiparkinson drug; dopaminergic agent; EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor |
guanosine triphosphate | [no description available] | medium | 2 | 0 | guanosine 5'-phosphate; purine ribonucleoside 5'-triphosphate | Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor |
hexestrol | [no description available] | medium | 1 | 0 | stilbenoid | |
urea | [no description available] | medium | 1 | 0 | isourea; monocarboxylic acid amide; one-carbon compound | Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
fluorescamine | [no description available] | medium | 1 | 0 | | |
mescaline | [no description available] | medium | 1 | 0 | methoxybenzenes; phenethylamine alkaloid; primary amino compound | hallucinogen |
nialamide | [no description available] | medium | 2 | 0 | organonitrogen compound; organooxygen compound | |
tranylcypromine | [no description available] | medium | 6 | 0 | 2-phenylcyclopropan-1-amine | |
dizocilpine maleate | [no description available] | medium | 3 | 0 | maleate salt; tetracyclic antidepressant | anaesthetic; anticonvulsant; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist |
ly 274614 | [no description available] | medium | 1 | 0 | | |
hydroxymaprotilin | [no description available] | medium | 1 | 0 | | |
cyclo(leucylglycine) | [no description available] | medium | 1 | 0 | | |
tianeptine | [no description available] | medium | 1 | 0 | dibenzothiazepine; monocarboxylic acid; organochlorine compound | |
cyanopindolol | [no description available] | medium | 1 | 0 | indoles | |
sodium fluoride | [no description available] | medium | 1 | 0 | fluoride salt | mutagen |
guanylyl imidodiphosphate | [no description available] | medium | 1 | 0 | nucleoside triphosphate analogue | |
azides | [no description available] | medium | 1 | 0 | pseudohalide anion | mitochondrial respiratory-chain inhibitor |
gtp gamma-4-azidoanilide | [no description available] | medium | 1 | 0 | | |
phenelzine | [no description available] | medium | 3 | 0 | primary amine | |
norfenfluramine | [no description available] | medium | 1 | 0 | amphetamines | |
ubenimex | [no description available] | medium | 1 | 0 | | |
thiorphan | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
u 78753e | [no description available] | medium | 1 | 0 | | |
cyclopentane | [no description available] | medium | 1 | 0 | cycloalkane; cyclopentanes; volatile organic compound | non-polar solvent |
3-methoxy-4-hydroxyphenylglycol sulfate | [no description available] | medium | 1 | 0 | alcohol; phenols | |
isoproterenol | [no description available] | medium | 2 | 0 | catechols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent |
naloxone | [no description available] | medium | 1 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary alcohol | antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist |
inosinic acid | [no description available] | medium | 1 | 0 | inosine phosphate; purine ribonucleoside 5'-monophosphate | Escherichia coli metabolite; human metabolite; mouse metabolite |
albuterol | [no description available] | medium | 1 | 0 | phenols; phenylethanolamines; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; environmental contaminant; xenobiotic |
dobutamine | [no description available] | medium | 1 | 0 | catecholamine; secondary amine | beta-adrenergic agonist; cardiotonic drug; sympathomimetic agent |
cysteine | [no description available] | medium | 1 | 0 | cysteinium | fundamental metabolite |
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | [no description available] | medium | 2 | 0 | methylpyridines; phenylpyridine; tetrahydropyridine | neurotoxin |
aconitine | [no description available] | medium | 1 | 0 | | |
lithium carbonate | [no description available] | medium | 1 | 0 | carbonate salt; lithium salt | antimanic drug |
4-hydroxyphenethylene glycol | [no description available] | medium | 1 | 0 | phenols | |
thorium dioxide | [no description available] | medium | 2 | 0 | thorium molecular entity | |
ergotamine | [no description available] | medium | 1 | 0 | peptide ergot alkaloid | alpha-adrenergic agonist; mycotoxin; non-narcotic analgesic; oxytocic; serotonergic agonist; vasoconstrictor agent |
1-propanol | [no description available] | medium | 1 | 0 | propan-1-ols; short-chain primary fatty alcohol | metabolite; protic solvent |
chlorine | [no description available] | medium | 1 | 0 | diatomic chlorine; gas molecular entity | bleaching agent |
phencyclidine | [no description available] | medium | 1 | 0 | benzenes; piperidines | anaesthetic; neurotoxin; NMDA receptor antagonist; psychotropic drug |
acid phosphatase | [no description available] | medium | 1 | 0 | | |
isocarboxazid | [no description available] | medium | 2 | 0 | benzenes | |
dronabinol | [no description available] | medium | 1 | 0 | benzochromene; diterpenoid; phytocannabinoid; polyketide | cannabinoid receptor agonist; epitope; hallucinogen; metabolite; non-narcotic analgesic |
hydrogen | [no description available] | medium | 1 | 0 | elemental hydrogen; elemental molecule; gas molecular entity | antioxidant; electron donor; food packaging gas; fuel; human metabolite |
oxazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; organochlorine compound | anxiolytic drug; environmental contaminant; xenobiotic |
isomethyleugenol | [no description available] | medium | 1 | 0 | isomethyleugenol | |
humulene | [no description available] | medium | 1 | 0 | alpha-humulene | |
indoleacetamide | [no description available] | low | 0 | 0 | indoles; monocarboxylic acid amide; N-acylammonia | bacterial metabolite; fungal metabolite; plant metabolite |
bisindolylmaleimide iii | [no description available] | low | 0 | 0 | indoles; maleimides | EC 2.7.11.13 (protein kinase C) inhibitor |
bisindolylmaleimide iv | [no description available] | low | 0 | 0 | indoles; maleimides | |
bisindolylmaleimide v | [no description available] | low | 0 | 0 | indoles | |
chetomin | [no description available] | low | 0 | 0 | indoles; organic disulfide; organic heteropentacyclic compound | Chaetomium metabolite; immunosuppressive agent |
dapi | [no description available] | low | 0 | 0 | indoles | fluorochrome |
3,3'-diindolylmethane | [no description available] | low | 0 | 0 | indoles | antineoplastic agent; P450 inhibitor |
gö6983 | [no description available] | low | 0 | 0 | indoles; maleimides | |
ic 261 | [no description available] | low | 0 | 0 | indoles | |
indapamide | [no description available] | low | 0 | 0 | indoles; organochlorine compound; sulfonamide | antihypertensive agent; diuretic |
indolepropanol phosphate | [no description available] | low | 0 | 0 | indoles; monoalkyl phosphate | |
linopirdine | [no description available] | low | 0 | 0 | indoles | |
3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one | [no description available] | low | 0 | 0 | indoles | |
ro 31-8220 | [no description available] | low | 0 | 0 | imidothiocarbamic ester; indoles; maleimides | EC 2.7.11.13 (protein kinase C) inhibitor |
ici 204,219 | [no description available] | low | 0 | 0 | carbamate ester; indoles; N-sulfonylcarboxamide | anti-asthmatic agent; leukotriene antagonist |
adrenochrome | [no description available] | low | 0 | 0 | indoles | |
5-bromoisatin | [no description available] | low | 0 | 0 | indoles | anticoronaviral agent |
etryptamine | [no description available] | low | 0 | 0 | indoles | |
hydroxytryptophol | [no description available] | low | 0 | 0 | indoles | |
indole-3-carbaldehyde | [no description available] | low | 0 | 0 | heteroarenecarbaldehyde; indole alkaloid; indoles | bacterial metabolite; human xenobiotic metabolite; marine metabolite; plant metabolite |
indican | [no description available] | low | 0 | 0 | aryl sulfate; indoles | human metabolite |
indoline | [no description available] | low | 0 | 0 | indoles | |
indoxyl acetate | [no description available] | low | 0 | 0 | indoles | |
methoxytryptophol | [no description available] | low | 0 | 0 | indoles | |
5-methoxyindole | [no description available] | low | 0 | 0 | indoles | |
mebhydroline | [no description available] | low | 0 | 0 | indoles | |
oxyphenisatin | [no description available] | low | 0 | 0 | indoles | |
5-Methoxyisatin | [no description available] | low | 0 | 0 | indoles | anticoronaviral agent |
indalpine | [no description available] | low | 0 | 0 | indoles | |
5-bromo-4-chloro-3-indoxyl phosphate | [no description available] | low | 0 | 0 | aryl phosphate; indoles; organobromine compound; organochlorine compound | chromogenic compound |
geneserine | [no description available] | low | 0 | 0 | indoles | |
ropinirole hydrochloride | [no description available] | low | 0 | 0 | indoles | |
tinazoline | [no description available] | low | 0 | 0 | indoles | |
n-acetyltryptamine | [no description available] | low | 0 | 0 | acetamides; indoles | |
mepindolol | [no description available] | low | 0 | 0 | indoles | |
eletriptan | [no description available] | low | 0 | 0 | indoles; N-alkylpyrrolidine; sulfone | non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
5-methoxyindole-3-carbaldehyde | [no description available] | low | 0 | 0 | indoles | |
6-chloroindole | [no description available] | low | 0 | 0 | indoles | |
5-Chloro-1H-indole-2,3-dione | [no description available] | low | 0 | 0 | indoles | anticoronaviral agent |
5-iodoisatin | [no description available] | low | 0 | 0 | indoles | anticoronaviral agent |
lyngbyatoxin a | [no description available] | low | 0 | 0 | indoles | |
indolactam v | [no description available] | low | 0 | 0 | indoles | |
indo-1 | [no description available] | low | 0 | 0 | indoles | fluorochrome |
ramosetron hydrochloride | [no description available] | low | 0 | 0 | indoles | |
ramosetron | [no description available] | low | 0 | 0 | indoles | |
5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole | [no description available] | low | 0 | 0 | indoles | |
echinuline | [no description available] | low | 0 | 0 | 2,5-diketopiperazines; indole alkaloid; indoles; olefinic compound | Aspergillus metabolite; marine metabolite; plant metabolite |
luzindole | [no description available] | low | 0 | 0 | acetamides; indoles | melatonin receptor antagonist |
almotriptan | [no description available] | low | 0 | 0 | indoles; sulfonamide; tertiary amine | non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
sb 200646 | [no description available] | low | 0 | 0 | indoles | |
tilivalline | [no description available] | low | 0 | 0 | indole alkaloid; indoles; phenols; pyrrolobenzodiazepine | bacterial metabolite; microtubule-stabilising agent; toxin |
asperlicin c | [no description available] | low | 0 | 0 | asperlicins; indoles; organic heterotetracyclic compound | Aspergillus metabolite; cholecystokinin antagonist |
sandoz-21-009 | [no description available] | low | 0 | 0 | indoles | |
pendolmycin | [no description available] | low | 0 | 0 | indoles | metabolite |
varespladib | [no description available] | low | 0 | 0 | aromatic ether; benzenes; dicarboxylic acid monoamide; indoles; monocarboxylic acid; primary carboxamide | anti-inflammatory drug; antidote; EC 3.1.1.4 (phospholipase A2) inhibitor |
leukodopachrome | [no description available] | low | 0 | 0 | hydroxy monocarboxylic acid; indoles | metabolite |
3,3-bis(4-hydroxy-3-methylphenyl)-1H-indol-2-one | [no description available] | low | 0 | 0 | indoles | |
3-methyleneindolenine | [no description available] | low | 0 | 0 | indoles | metabolite |
sb 216763 | [no description available] | low | 0 | 0 | indoles; maleimides | |
enzastaurin | [no description available] | low | 0 | 0 | indoles; maleimides | |
brevianamide f | [no description available] | low | 0 | 0 | dipeptide; indoles; pyrrolopyrazine | metabolite |
3-(hydroxyacetyl)indole | [no description available] | low | 0 | 0 | indoles | |
roxindole | [no description available] | low | 0 | 0 | indoles | alpha-adrenergic antagonist; serotonergic drug |
5-Fluoroisatin | [no description available] | low | 0 | 0 | indoles | anticoronaviral agent |
beta-indol-3-yl-glucoside | [no description available] | low | 0 | 0 | glycoside; indoles | |
2-methyl-3-(phenylmethylthio)-1H-indole | [no description available] | low | 0 | 0 | indoles | |
indole-3-acetonitrile | [no description available] | low | 0 | 0 | indoles; nitrile | auxin; human xenobiotic metabolite; plant hormone; plant metabolite |
10H-[1]benzothiolo[3,2-b]indole | [no description available] | low | 0 | 0 | indoles | |
2,2,2-trifluoro-N-[2-(1H-indol-3-yl)ethyl]acetamide | [no description available] | low | 0 | 0 | indoles; secondary carboxamide; trifluoroacetamide | |
physovenine | [no description available] | low | 0 | 0 | indoles | |
dendrobine | [no description available] | low | 0 | 0 | indoles | |
ck-0944666 | [no description available] | low | 0 | 0 | benzamides; indoles; organofluorine compound | actin polymerisation inhibitor |
methyl indole-3-carboxylate | [no description available] | low | 0 | 0 | indoles; methyl ester | metabolite |
2-(1H-indol-3-ylthio)acetic acid | [no description available] | low | 0 | 0 | indoles | |
3-(4-pyridyl)-1h-indole | [no description available] | low | 0 | 0 | indoles | |
1-(2,3-dihydroindol-1-yl)-2-(5-pyridin-4-yl-2-tetrazolyl)ethanone | [no description available] | low | 0 | 0 | indoles | |
2-(6-cyano-1-indolyl)-N-cyclohexylacetamide | [no description available] | low | 0 | 0 | indoles | |
1-methyl-2-[(4-methyl-1-piperidinyl)methyl]-3-indolecarbonitrile | [no description available] | low | 0 | 0 | indoles | |
4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-N-(2-oxolanylmethyl)-2-thiazolamine | [no description available] | low | 0 | 0 | indoles | |
N-[4-(2-methyl-1-methylsulfonyl-2,3-dihydroindol-5-yl)-2-thiazolyl]-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | indoles | |
1-[5-(2-amino-5-methyl-4-thiazolyl)-2,3-dihydroindol-1-yl]-1-butanone | [no description available] | low | 0 | 0 | indoles | |
2-(2-methyl-1H-indol-3-yl)ethanol | [no description available] | low | 0 | 0 | indoles | |
2-(2-ethyl-1-piperidinyl)-1-(2-methyl-1H-indol-3-yl)ethanone | [no description available] | low | 0 | 0 | indoles | |
1-(2,6-dimethyl-1H-indol-3-yl)-2-(1-pyrrolidinyl)ethanone | [no description available] | low | 0 | 0 | indoles | |
1-methyl-2-[(phenylthio)methyl]-3-indolecarbonitrile | [no description available] | low | 0 | 0 | indoles | |
1-(2,3-dihydroindol-1-yl)-2-(phenylthio)ethanone | [no description available] | low | 0 | 0 | indoles | |
2-(2,3-dihydroindol-1-yl)-N,N-dimethylethanamine | [no description available] | low | 0 | 0 | indoles | |
8-(1H-indol-3-ylmethylidene)-6,10-dioxaspiro[4.5]decane-7,9-dione | [no description available] | low | 0 | 0 | indoles | |
N-(1-acetyl-2-chloro-3-indolyl)-2-chloroacetamide | [no description available] | low | 0 | 0 | indoles | |
4-(5-methoxy-1,2-dimethyl-3-indolyl)-2-thiazolamine | [no description available] | low | 0 | 0 | indoles | |
N-(1-acetyl-2,3-dihydroindol-5-yl)-4-methylbenzamide | [no description available] | low | 0 | 0 | indoles | |
oncrasin-1 | [no description available] | low | 0 | 0 | arenecarbaldehyde; indoles; monochlorobenzenes | antineoplastic agent; apoptosis inducer |
1-(2-methyl-1H-indol-3-yl)-2-(2-thiazolylamino)ethanone | [no description available] | low | 0 | 0 | indoles | |
N-(2-fluorophenyl)-2-[3-(1-oxopropyl)-1-indolyl]acetamide | [no description available] | low | 0 | 0 | indoles | |
2-(3-acetyl-1-indolyl)-N-(2,4-dimethylphenyl)acetamide | [no description available] | low | 0 | 0 | indoles | |
4-amino-2-[[2-(2,3-dihydroindol-1-yl)-2-oxoethyl]thio]-5-pyrimidinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | indoles | |
LSM-33266 | [no description available] | low | 0 | 0 | indoles | |
1-oxo-3-(1-piperidinyl)-5,6,7,8-tetrahydropyrrolo[1,2-a]indole-2-carbonitrile | [no description available] | low | 0 | 0 | indoles | |
[1-(2-phenoxyethyl)-3-indolyl]-(1-pyrrolidinyl)methanethione | [no description available] | low | 0 | 0 | indoles | |
N-[4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-2-thiazolyl]acetamide | [no description available] | low | 0 | 0 | indoles | |
1-[2-(1H-indol-3-yl)ethyl]-5,6,7,8-tetrahydroquinolin-4-one | [no description available] | low | 0 | 0 | indoles | |
N,N-diethylcarbamodithioic acid [2-(2-methyl-1H-indol-3-yl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | indoles | |
1-(3-phenoxypropyl)-3-indolecarbonitrile | [no description available] | low | 0 | 0 | indoles | |
1-[(3,4-dichlorophenyl)methyl]indole-2,3-dione | [no description available] | low | 0 | 0 | indoles | |
2-[[1-[(3-fluorophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide | [no description available] | low | 0 | 0 | indoles | |
1-[2-(2,5-dimethyl-1H-indol-3-yl)ethyl]-3-methyl-1-(thiophen-2-ylmethyl)thiourea | [no description available] | low | 0 | 0 | indoles | |
2-(1H-indol-3-yl)-2-oxo-N-(2-thiazolyl)acetamide | [no description available] | low | 0 | 0 | indoles | |
N-(2-furanylmethyl)-2-[3-(1-oxo-2-phenoxyethyl)-1-indolyl]acetamide | [no description available] | low | 0 | 0 | indoles | |
4-(1H-indol-3-yl)butanoic acid [2-(4-amino-1,3-dimethyl-2,6-dioxo-5-pyrimidinyl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | indoles | |
2,5-dimethyl-3-furancarboxylic acid [2-(2,3-dihydroindol-1-yl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | indoles | |
2-chloro-3-pyridinecarboxylic acid [2-(2,3-dihydroindol-1-yl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | indoles | |
4-(1H-indol-3-yl)butanoic acid [2-(3-methoxyanilino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | indoles | |
2-(2,3-dihydro-1H-inden-5-yloxy)-1-(2,3-dihydroindol-1-yl)ethanone | [no description available] | low | 0 | 0 | indoles | |
1H-indol-3-yl(pyridin-2-yl)methanol | [no description available] | low | 0 | 0 | indoles | |
N-(1H-indol-5-yl)-2-thiophenecarboxamide | [no description available] | low | 0 | 0 | indoles | |
4-[[1-[(3,4-dichlorophenyl)methyl]-3-indolyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one | [no description available] | low | 0 | 0 | indoles | |
2-methyl-3-[(2-methyl-1H-indol-3-yl)-(2-pyridinyl)methyl]-1H-indole | [no description available] | low | 0 | 0 | indoles | |
N-[amino-[2-(1H-indol-3-yl)ethylimino]methyl]-4-chlorobenzamide | [no description available] | low | 0 | 0 | indoles | |
3-[2-(2,4-dimethyl-3-furanyl)-2-oxoethyl]-3-hydroxy-1-(2-phenylethyl)-2-indolone | [no description available] | low | 0 | 0 | indoles | |
1-[2-(hydroxymethyl)-1-benzimidazolyl]-3-(1-indolyl)-2-propanol | [no description available] | low | 0 | 0 | indoles | |
6-(2-chlorophenyl)-3-methyl-2-[4-morpholinyl(oxo)methyl]-1,5,6,7-tetrahydroindol-4-one | [no description available] | low | 0 | 0 | indoles | |
3-methyl-4-oxo-1,5,6,7-tetrahydroindole-2-carboxylic acid (4-methylcyclohexyl) ester | [no description available] | low | 0 | 0 | indoles | |
5-[[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]methyl]-2-furancarboxylic acid methyl ester | [no description available] | low | 0 | 0 | indoles | |
N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide | [no description available] | low | 0 | 0 | indoles | |
2-[(prop-2-enylthio)-(4,5,6,7-tetrahydro-1H-indol-2-yl)methylidene]propanedinitrile | [no description available] | low | 0 | 0 | indoles | |
2-[[5-(dimethylsulfamoyl)-1H-indol-3-yl]methylidene]propanedioic acid diethyl ester | [no description available] | low | 0 | 0 | indoles | |
5-methyl-1-[3-(2-methylphenoxy)propyl]indole-2,3-dione | [no description available] | low | 0 | 0 | indoles | |
N-[2-(1H-indol-3-yl)ethyl]-4-(phenylmethyl)-5-thieno[3,2-b]pyrrolecarboxamide | [no description available] | low | 0 | 0 | indoles | |
1-[cyclopropyl(oxo)methyl]-N-(2-hydroxyethyl)-N-(phenylmethyl)-2,3-dihydroindole-5-sulfonamide | [no description available] | low | 0 | 0 | indoles | |
5-bromo-1-(1-oxopropyl)-N,N-dipropyl-2,3-dihydroindole-7-sulfonamide | [no description available] | low | 0 | 0 | indoles | |
4-(1-methyl-3-indolyl)-N-propan-2-ylbutanamide | [no description available] | low | 0 | 0 | indoles | |
4-(2,3-dihydroindol-1-yl)-N-[3-(N-ethyl-3-methylanilino)propyl]-3-(1-imidazolyl)-4-oxobutanamide | [no description available] | low | 0 | 0 | indoles | |
1-[[5-bromo-1-[cyclopropyl(oxo)methyl]-2,3-dihydroindol-7-yl]sulfonyl]-4-piperidinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | indoles | |
N-[2-(2-methyl-1-indolyl)ethyl]benzamide | [no description available] | low | 0 | 0 | indoles | |
3-[[5-bromo-1-[cyclopropyl(oxo)methyl]-2,3-dihydroindol-7-yl]sulfonyl]-N-[(5-methyl-2-furanyl)methyl]propanamide | [no description available] | low | 0 | 0 | indoles | |
acetic acid [2-(1-acetyl-6-indolyl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | indoles | |
N-[2-(1-cyclohexenyl)ethyl]-1-[cyclopropyl(oxo)methyl]-2,3-dihydroindole-5-sulfonamide | [no description available] | low | 0 | 0 | indoles | |
4-[2-[[1-[(2-methylphenyl)methyl]-3-indolyl]sulfonyl]-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | indoles | |
N-[4-(dimethylamino)phenyl]-2-(1-oxo-[1,2,4]triazino[4,5-a]indol-2-yl)acetamide | [no description available] | low | 0 | 0 | indoles | |
N-(3-methoxyphenyl)-2-(1-methyl-3-indolyl)acetamide | [no description available] | low | 0 | 0 | indoles | |
cyclobutyl-[5-[(2-ethyl-1-piperidinyl)sulfonyl]-2,3-dihydroindol-1-yl]methanone | [no description available] | low | 0 | 0 | indoles | |
n-(1-methyl-5-indolyl)-n'-(3-methyl-5-isothiazolyl)urea | [no description available] | low | 0 | 0 | 1,2-thiazoles; indoles; ureas | receptor modulator; serotonergic antagonist |
n-pentanoyl-2-benzyltryptamine | [no description available] | low | 0 | 0 | indoles | |
2-[[1-(phenylmethyl)-3-indolyl]thio]-N-(2-thiazolyl)acetamide | [no description available] | low | 0 | 0 | indoles | |
[1-[2-(2-methylphenoxy)ethyl]-3-indolyl]-(4-methyl-1-piperazinyl)methanethione | [no description available] | low | 0 | 0 | indoles | |
1-(Chloroacetyl)-3-(1H-indol-3-yl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-4-ol | [no description available] | low | 0 | 0 | indoles | anticoronaviral agent |
N-[(1,2-dimethyl-5-indolyl)methyl]-2-methyl-3-nitrobenzamide | [no description available] | low | 0 | 0 | indoles | |
N-(2-furanylmethyl)-2-[[5-[(2-methyl-1H-indol-3-yl)methyl]-1,3,4-oxadiazol-2-yl]thio]acetamide | [no description available] | low | 0 | 0 | indoles | |
l 663536 | [no description available] | low | 0 | 0 | aryl sulfide; indoles; monocarboxylic acid; monochlorobenzenes | antineoplastic agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; leukotriene antagonist |
2-[(1-methyl-3-indolyl)thio]-N-(2-thiazolyl)acetamide | [no description available] | low | 0 | 0 | indoles | |
Nb-Palmitoyltryptamine | [no description available] | low | 0 | 0 | indoles | |
rs 17053 | [no description available] | low | 0 | 0 | indoles | |
N-[2-(2-chlorophenoxy)ethyl]-2-(1H-indol-3-yl)-2-oxoacetamide | [no description available] | low | 0 | 0 | indoles | |
1-(1H-indol-3-yl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]ethanone | [no description available] | low | 0 | 0 | indoles | |
1-[2-(5-chloro-2-methyl-1H-indol-3-yl)ethyl]-3-ethyl-1-(2-furanylmethyl)thiourea | [no description available] | low | 0 | 0 | indoles | |
5-bromo-N-[(1,2-dimethyl-5-indolyl)methyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | indoles | |
1-[(1,2-dimethyl-5-indolyl)methyl]-3-(phenylmethyl)thiourea | [no description available] | low | 0 | 0 | indoles | |
4-chloro-N-[2-(1H-indol-3-yl)-1-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)ethyl]benzamide | [no description available] | low | 0 | 0 | indoles | |
1-cyclohexyl-3-[(1,2-dimethyl-5-indolyl)methyl]urea | [no description available] | low | 0 | 0 | indoles | |
5-bromo-N-[2-(2-methyl-1-indolyl)ethyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | indoles | |
le 300 | [no description available] | low | 0 | 0 | indoles | |
4-[(1,2-dimethyl-5-indolyl)methylamino]-4-oxobutanoic acid | [no description available] | low | 0 | 0 | indoles | |
5-Nitroisatin | [no description available] | low | 0 | 0 | indoles | anticoronaviral agent |
1-[2-(2,4-dichlorophenyl)-2-(1H-indol-3-yl)ethyl]-3-[3-(dimethylamino)propyl]thiourea | [no description available] | low | 0 | 0 | indoles | |
N-[2-[4-(dimethylamino)phenyl]-2-(1H-indol-3-yl)ethyl]benzamide | [no description available] | low | 0 | 0 | indoles | |
2,6-difluoro-N-[2-[3-[(2-fluorophenyl)methylthio]-1-indolyl]ethyl]benzamide | [no description available] | low | 0 | 0 | indoles | |
ro 60-0175 | [no description available] | low | 0 | 0 | indoles; organochlorine compound; organofluorine compound; primary amino compound | |
N-[(1,2-dimethyl-5-indolyl)methyl]-2-(4-nitrophenyl)acetamide | [no description available] | low | 0 | 0 | indoles | |
2-[[4-amino-5-(3,4-dimethoxyphenyl)-1,2,4-triazol-3-yl]thio]-1-(1H-indol-3-yl)-2-phenylethanone | [no description available] | low | 0 | 0 | indoles | |
1-acetyl-N-[3-(N-ethyl-3-methylanilino)propyl]-2,3-dihydroindole-5-sulfonamide | [no description available] | low | 0 | 0 | indoles | |
3-[3-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]propyl]-1H-benzimidazol-2-one | [no description available] | low | 0 | 0 | indoles | |
koumine | [no description available] | low | 0 | 0 | indoles | |
AG-370 | [no description available] | low | 0 | 0 | indoles | |
(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | [no description available] | low | 0 | 0 | dihydroxy monocarboxylic acid; indoles; organofluorine compound | |
apaziquone | [no description available] | low | 0 | 0 | indoles | |
amaranthin betacyanin | [no description available] | low | 0 | 0 | disaccharide derivative; indoles; olefinic compound; tetrahydropyridine | biological pigment; plant metabolite |
(5-ethyl-8-methyl-[1,2,4]triazino[5,6-b]indol-3-yl)hydrazine | [no description available] | low | 0 | 0 | indoles | |
chaetoglobosin A | [no description available] | low | 0 | 0 | cytochalasan alkaloid; epoxide; indoles; macrocycle; secondary alpha-hydroxy ketone | Chaetomium metabolite |
LSM-18452 | [no description available] | low | 0 | 0 | indoles | |
(2R,4R)-4-(1-acetyl-3-indolyl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-N-(phenylmethyl)-3,4-dihydro-2H-pyran-6-carboxamide | [no description available] | low | 0 | 0 | indoles | |
vilazodone | [no description available] | low | 0 | 0 | 1-benzofurans; indoles; monocarboxylic acid amide; N-alkylpiperazine; N-arylpiperazine; nitrile | antidepressant; serotonergic agonist; serotonin uptake inhibitor |
cyclo(glycyltryptophyl) | [no description available] | low | 0 | 0 | indoles | metabolite |
2-[(1R,3S)-3-(7-bromo-2-methyl-1H-indol-3-yl)-2,2-dimethylcyclopropyl]acetonitrile | [no description available] | low | 0 | 0 | indoles | |
(11S,14S)-Cyclo-(L-Trp-L-Phe) | [no description available] | low | 0 | 0 | indoles | Aspergillus metabolite |
LSM-3706 | [no description available] | low | 0 | 0 | indoles | |
LSM-3511 | [no description available] | low | 0 | 0 | indoles | |
LSM-2818 | [no description available] | low | 0 | 0 | indoles | |
tryprostatin b | [no description available] | low | 0 | 0 | dipeptide; indole alkaloid; indoles; pyrrolopyrazine | |
l 779976 | [no description available] | low | 0 | 0 | benzimidazoles; indoles; piperidinecarboxamide; primary amino compound; secondary carboxamide | neuroprotective agent; somatostatin receptor agonist |
tmc-95a | [no description available] | low | 0 | 0 | indoles; lactam; macrocycle; phenols; secondary alcohol; tertiary alcohol | antimicrobial agent; antineoplastic agent; bacterial metabolite; fungal metabolite; proteasome inhibitor |
nematophin | [no description available] | low | 0 | 0 | indoles | |
molindone hydrochloride | [no description available] | low | 0 | 0 | indoles | |
varespladib methyl | [no description available] | low | 0 | 0 | aromatic ether; benzenes; indoles; methyl ester; primary carboxamide | anti-inflammatory drug; antidote; EC 3.1.1.4 (phospholipase A2) inhibitor; prodrug |
am 694 | [no description available] | low | 0 | 0 | aromatic ketone; indoles; organofluorine compound; organoiodine compound; synthetic cannabinoid | cannabinoid receptor agonist |
tryprostatin a | [no description available] | low | 0 | 0 | aromatic ether; dipeptide; indole alkaloid; indoles; pyrrolopyrazine | breast cancer resistance protein inhibitor |
way-362450 | [no description available] | low | 0 | 0 | indoles | |
fumiquinazoline f | [no description available] | low | 0 | 0 | fumiquinazoline; indoles; pyrazinoquinazoline | |
5-chloro-2-methyl-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole | [no description available] | low | 0 | 0 | indoles | |
a 443654 | [no description available] | low | 0 | 0 | indoles | |
noradrenochrome | [no description available] | low | 0 | 0 | indoles | |
sotrastaurin | [no description available] | low | 0 | 0 | indoles; maleimides; N-alkylpiperazine; N-arylpiperazine; quinazolines | anticoronaviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunosuppressive agent |
tmc-95b | [no description available] | low | 0 | 0 | indoles; lactam; macrocycle; phenols; secondary alcohol; tertiary alcohol | antimicrobial agent; antineoplastic agent; fungal metabolite; proteasome inhibitor |
chromopyrrolic acid | [no description available] | low | 0 | 0 | indoles; pyrroledicarboxylic acid | bacterial metabolite |
arq 197 | [no description available] | low | 0 | 0 | indoles | |
quisinostat | [no description available] | low | 0 | 0 | indoles | |
pf-562,271 | [no description available] | low | 0 | 0 | indoles | |
Dihydro-beta-erythroidine hydrobromide | [no description available] | low | 0 | 0 | indoles | |
N-[5-(2,3-dihydroindol-1-ylsulfonyl)-1,3,4-thiadiazol-2-yl]-3-methylbutanamide | [no description available] | low | 0 | 0 | indoles | |
complestatin | [no description available] | low | 0 | 0 | cyclic ether; heterodetic cyclic peptide; indoles; organic heterobicyclic compound; organochlorine compound; peptide antibiotic; polyphenol | anti-HIV-1 agent; antimicrobial agent; HIV-1 integrase inhibitor; metabolite |
neuroprotectin a | [no description available] | low | 0 | 0 | cyclic ether; heterodetic cyclic peptide; indoles; organochlorine compound; polyphenol | HIV-1 integrase inhibitor; metabolite |
2-[3-[[2-oxo-2-(1-pyrrolidinyl)ethyl]thio]-1-indolyl]-N,N-di(propan-2-yl)acetamide | [no description available] | low | 0 | 0 | indoles | |
1-[3-[(2R,4R)-2-[[4-(hydroxymethyl)phenyl]methoxy]-6-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]-3,4-dihydro-2H-pyran-4-yl]-1-indolyl]ethanone | [no description available] | low | 0 | 0 | indoles | |
3-[(1-methyl-3-indolyl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-one | [no description available] | low | 0 | 0 | indoles | |
2-[1-[2-(diethylamino)-2-oxoethyl]-3-indolyl]-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxoacetamide | [no description available] | low | 0 | 0 | indoles | |
1-[(2-oxo-1,3-dihydroindol-5-yl)sulfonyl]-4-piperidinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | indoles | |
N-(4-propan-2-ylphenyl)-1-[(1,3,3-trimethyl-2-oxo-5-indolyl)sulfonyl]-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | indoles | |
N-[4-[1-(1-oxopropyl)-2,3-dihydroindol-5-yl]-2-thiazolyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | indoles | |
cink4 | [no description available] | low | 0 | 0 | indoles | |
chondramide c | [no description available] | low | 0 | 0 | chondramide; indoles; phenols | antineoplastic agent; bacterial metabolite |
2-[[1-[(3-chlorophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide | [no description available] | low | 0 | 0 | indoles | |
2-[[1-[(3-bromophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide | [no description available] | low | 0 | 0 | indoles | |
wasalexin a | [no description available] | low | 0 | 0 | indoles | |
chondramide a | [no description available] | low | 0 | 0 | chondramide; indoles; phenols | antineoplastic agent; bacterial metabolite |
(3R)-4-[2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)-4-pyrimidinyl]-3-methylmorpholine | [no description available] | low | 0 | 0 | indoles | |
gsk2656157 | [no description available] | low | 0 | 0 | biaryl; indoles; methylpyridines; organofluorine compound; pyrrolopyrimidine; tertiary carboxamide | antineoplastic agent; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; PERK inhibitor |
AZD3463 | [no description available] | low | 0 | 0 | aminopiperidine; aminopyrimidine; indoles; monomethoxybenzene; organochlorine compound; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
osimertinib | [no description available] | low | 0 | 0 | acrylamides; aminopyrimidine; biaryl; indoles; monomethoxybenzene; secondary amino compound; secondary carboxamide; substituted aniline; tertiary amino compound | antineoplastic agent; epidermal growth factor receptor antagonist |
acarbose | [no description available] | low | 0 | 0 | chondramide; indoles; organochlorine compound; phenols | antineoplastic agent; bacterial metabolite |
chondramide d | [no description available] | low | 0 | 0 | chondramide; indoles; phenols | antineoplastic agent; bacterial metabolite |
THZ531 | [no description available] | low | 0 | 0 | aminopyrimidine; enamide; indoles; N-acylpiperidine; organochlorine compound; secondary amino compound; secondary carboxamide | antineoplastic agent; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor |
lugdunin | [no description available] | low | 0 | 0 | homodetic cyclic peptide; indoles; macrocycle; peptide antibiotic; thiazolidines | human metabolite; rat metabolite |
tegaserod | [no description available] | low | 0 | 0 | carboxamidine; guanidines; hydrazines; indoles | gastrointestinal drug; serotonergic agonist |
brassilexin | [no description available] | low | 0 | 0 | indoles | |
indolmycin | [no description available] | low | 0 | 0 | 1,3-oxazoles; indoles; secondary amino compound | antibacterial agent; antimicrobial agent; bacterial metabolite; EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitor |
N'-(1h-indol-3-ylmethylene)benzohydrazide | [no description available] | low | 0 | 0 | indoles | |